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1. Introduction 
 
1.1. Prions 
 
The mystery behind scrapie, kuru and mad cow disease has finally been unraveled. 
Additionally, the discovery of prions has opened up new avenues to better understand 
the pathogenesis of other more common dementias, such as Alzheimer’s disease 
[Petterson, 1997]. These words have been told 10 years ago when Stanley B. Prusiner 
recieved the Nobel Prize in medicine for his discovery of prions – a new biological 
principle of infection. 
Prions are infectious proteins. In mammals, prions reproduce by recruiting normal 
cellular prion precursor protein (PrPC) and thus stimulate its conversion to the disease-
causing (scrapie) isoform (PrPSc). A major feature that distinguishes prions from viruses 
is that PrPSc is encoded by a chromosomal gene [Prusiner, 1998]. Limited proteolysis of 
PrPSc produces a smaller, protease-resistant molecule of approximately 142 amino acids, 
designated PrP 27–30, which polymerizes into amyloid [McKinley et al., 1991]. 
 
A B
 
Figure 1: Structures of Prion Protein isoforms: panel A shows the α-helical structure of Syrian hamster 
recombinant PrP 90-231, which presumably resembles that of the cellular isoform (PrPC); panel B shows 
a plausible model of the tertiary structure of human PrPSc [Prusiner, 2001].  
 
The polypeptide chains of PrPC and PrPSc are identical in composition but differ in 
their three-dimensional folded structures (conformations). PrPC is rich in α-helixes and 
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has little β-sheet conformation, whereas the β-sheet conformation is the main 
component of PrPSc (Fig. 1) [Pan et al., 1993]. 
Several new concepts have emerged from studies of prions. First of all, prions are 
the only known example of nucleic acid-free infectious pathogens. All other infectious 
agents contain either RNA or DNA, which direct the synthesis of their proteins. 
Secondly, prion diseases (Table 1) are the only group of illnesses, which while caused 
by a single pathogen may manifest as infectious, genetic, or sporadic disorders. Thirdly, 
prion diseases result from the accumulation of PrPSc, which has a substantially different 
conformation from that of its precursor, PrPC. Fourthly, PrPSc can have a variety of 
conformations, all of which seem to be associated with a specific disease. How a 
particular conformation of PrPSc is imparted to PrPC during replication in order to 
produce a nascent PrPSc with the same conformation still remains unknown [Prusiner, 
2001]. 
 
Table 1: Prion diseases [Prusiner, 1998]. 
Disease Host Mechanism of pathogenesis 
Kuru Fore people Infection through ritualistic cannibalism 
Iatrogenic Creutzfeldt-Jacob disease (CJD) Humans Infection from prion-contaminated human 
growth hormone (HGH) 
Sporadic CJD Humans Somatic mutations or spontaneous 
conversion of PrPC into PrPSc
Familial CJD Humans Germ-line mutations in PrP gene 
New variant CJD Humans Infection from bovine prions 
Fatal familial insomnia (FFI) Humans Germ-line mutations in PrP gene 
Gerstmann-Sträusller-Sheinker disease (GSS) Humans Germ-line mutations in PrP gene 
Fatal sporadic insomnia (FSI) Humans Somatic mutations or spontaneous 
conversion of PrPC into PrPSc
Scrapie Sheep Infection of genetically susceptible sheep 
Bovine spongiform encephalopathy (BSE) Cattle Infection with prion-contaminated meat 
and bone meal (MBM) 
Transmissible mink encephalopathy (TME) Mink Infection with prions from sheep or cattle 
Chronic wasting disease (CWD) Deer, elk Unknown 
Feline spongiform encephalopathy (FSE) Cats Infection with prion-contaminated bovine 
tissues or MBM 
Exotic ungulate encephalopathy Greater 
Kudu, nyala 
Infection with prion-contaminated MBM 
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The existence of prion strains raises the question of how heritable biologic 
information can be encrypted in a molecule other than a nucleic acid [Dickinson et al., 
1968; Ridley and Baker, 1996]. Different strains of prions have been defined according 
to the rapidity with which they cause central nervous system damage and by the 
distribution of neuronal vacuolation [Dickinson et al., 1968]. Patterns of PrPSc 
deposition have also been used to characterize these strains [DeArmond et al., 1987; 
Bruce et al., 1989]. There is growing evidence that the diversity of prions is encoded in 
the conformation of the PrPSc protein [Telling et al., 1996; Safar et al., 1998]. Studies 
involving the transmission of fatal familial insomnia and familial Creutzfeldt–Jakob 
disease to mice expressing a chimeric human–mouse PrP transgene have shown that the 
tertiary and quaternary structure of PrPSc contains strain-specific information [Telling et 
al., 1996]. Studies of patients with fatal sporadic insomnia have extended these findings 
[Mastrianni et al., 1999], making it clear that PrPSc acts as a template for the conversion 
of PrPC into nascent PrPSc. 
 
1.2. Neurodegenerative diseases 
 
Although prion diseases, due to possible infectivity, can become a major problem 
in the future, currently the number of cases is very low in comparison to other 
neurodegenerative diseases (Table 2). Alzheimer’s disease is the most common 
neurodegenerative disorder followed by Parkinson’s disease as the second most 
common one. According to the most current available data, there are more than 5 
million Alzheimer’s disease cases [www.alz.org] and more than 1 million Parkinson’s 
disease cases [www.pdf.org] in the United States, which is more than 2 % of the whole 
population of the country.  
Alzheimer’s Association reports that currently 19 % Americans between age 75 
and 84 and 42 % of those over age 85 are affected by this syndrome. As life expectancy 
continues to increase, the number of neurodegenerative diseases is growing. Although 
worldwide prevalence of Alzheimer’s disease in 2006 was approximately 26.6 million, 
the forecast for 2050 suggest that more than 1 % of the world population will be 
affected [Brookmeyer et al., 2007].  
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There is increasing evidence, showing that different neurodegenerative diseases 
have common cellular and molecular mechanisms including protein aggregation. The 
aggregates usually consist of fibers containing misfolded protein with a dominant β-
sheet conformation, termed amyloid [Ross and Poirier, 2004]. 
 
Table 2: Prevalence of neurodegenerative diseases in the United States in 2000 [Prusiner, 2001]. 
Disease Number of cases per 100000 of population 
Prion disease 400 < 1 
Pick’s disease 5000 2 
Spinocerebellar ataxias 12000 4 
Progressive supranuclear palsy 15000 5 
Amyotrophic lateral sclerosis 20000 7 
Huntington’s disease 30000 11 
Frontotemporal dementia 40000 14 
Parkinson’s disease 1000000 360 
Alzheimer’s disease 4000000 1450 
 
1.3. Amyloid 
 
The definition of “amyloid” has varied over the years. Back in 1854, the German 
scientist Rudolf Virchow described iodine staining of the cerebral corpora amylacea 
that had an abnormal macroscopic appearance. As the sample showed typical starch-
iodine reaction, he assumed that the substance contained a carbohydrate moiety 
[Virchow 1854] and named it amyloid. Later Friedreich and Kekulé proved the absence 
of carbohydrates along with the presence of a protein, and amyloid became known as a 
class of proteins [Sipe and Cohen, 2000]. Further studies made a more precise 
description possible. In clinical practice amyloid was characterized through its affinity 
to Congo red and green birefringence in polarized light after staining with Congo red 
[Jin et al., 2003]. Secondary structure studies showed a β-sheet rich structure [Glenner, 
1980] and electron microscopy discovered that the amyloid material is made of ordered 
aggregates – filaments and fibers [Perutz et al., 2002].  Most recently, amyloid is 
defined as an extracellular deposit of protein fibrils with the specific organization, 
which has characteristic properties observed after staining with Congo red [Westermark 
et al., 2005]. It is suggested that the term “amyloid” would be restricted to the in vivo 
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material. Other fibrillar material should be called “amyloid-like” [Westermark, 2005]. 
Nevertheless, the term “amyloid fibrils” is widely used for any type of fibrillar 
aggregates [Dobson, 2003; Wetzel et al., 2007] and seems to be popular enough to 
override official guidelines.  
For many years it was generally assumed that the ability to form amyloid fibrils 
was limited to the proteins, implicated in diseases, and that these proteins possess 
specific sequence motifs encoding the amyloid core. But during the last decade it was 
shown that many proteins, not associated with diseases can form amyloid-like fibrils 
[Fandrich et al., 2001; Nielsen et al., 2001; Munishkina et al., 2003]. Homopolypeptides, 
such as polylysine or polythreonine [Fandrich and Dobson, 2002], and even short 
oligopeptides, containing 4-6 amino acids [Lopez de la Paz et al., 2002; Baumketner 
and Shea, 2005] are able to be converted into amyloid fibers, as well.   
Although amyloid precursor proteins are very different in amino acid sequence, 
secondary structure and size, the mature fibers show similar highly organized 
morphology and mechanisms of toxicity [Dobson, 2004]. It has been suggested that 
nearly all proteins have the ability to form amyloid under certain conditions, and that 
this can be considered a generic feature of polypeptide chains [Stefani and Dobson, 
2003]. 
 
1.4. Structure of amyloid fibrils 
 
A number of studies were aimed at obtaining an insight into the macromolecular 
structure of amyloid fibrils using atomic force microscopy [Jansen et al. 2005; Khurana 
et al. 2003], electron microscopy [Jimenez et al., 2001, 2002] and even fluorescence 
microscopy [Ban et al., 2006]. Despite the diversity of amyloid-forming proteins, 
structural studies agree that all fibrils are composed of protofilaments – the smallest 
fibrillar subunits. Protofilaments can assemble into protofibrils and fibrils. Dimensions 
of protofilaments and their assemblies depend on the substrate protein (Fig. 2). 
Although various models of fibril assembly from protofilaments can be supported by 
microscopy images of selected specimen, overall mature fibrils are too different and too 
inhomogenous to be described by a single model. Even the well-studied insulin amyloid  
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A B 
C 
Figure 2: Models of hierarchical assembly of protofilaments into amyloid fibrils. Protofilament pairs wind 
together to form protofibrils, and each two protofibrils wind to form a fibril in case of α-synuclein (A); 
three protofilaments wind together to form a protofibril, and two protofibrils (or six protofilaments) wind 
to form a fibril in case of the B1 domain of protein G (B), and protofilament pairs wind together to form 
protofibrils, and each two protofibrils wind to form a type I fibril. Type II fibrils are the result of winding 
of type I fibrils in the case of insulin (C) [adapted from Khurana et al. 2003]. 
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still raises a lot of questions in developing a common definition of the mature fibril 
structure due to its polymorphism (Fig. 3). 
 
 
Figure 3: Generalized scheme of the multipathway fibrillization of insulin. The lateral interaction of early, 
prefibrillar forms with protofibrils and protofilaments, followed by the lateral association of 
protofilaments, is a self-assembly route alternative to the hierarchical intertwining of protofilaments. The 
observed polymorphism of mature amyloid samples suggests that, under the given conditions, insulin 
fibrillization proceeds from both pathways [Jansen et al., 2005].  
 
The internal structure of amyloid protofilaments was studied mainly by X-ray 
diffraction [Geddes et al., 1968; Sunde et al., 1997] and solid state NMR [Tycko 2000, 
2003]. The x-ray diffraction patterns of amyloid fibrils reveal a periodic molecular 
structure consisting of polypeptide chains in the extended β-conformation, forming 
hydrogen-bonded-β-sheets which run parallel to the long axis of the fibril, whereas the 
constituent β-strands are arranged perpendicular to this axis. This data has led 
establishing the cross-β structure model of amyloid protofilaments (Fig. 4). Although 
other models, such as the β-helix [Raetz and Roderick, 1995; Lazo and Downing, 1998] 
and predominantly native structures [Bouset et al., 2002; Inouye et al., 1998] were 
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described, the cross-β structure has a big support, including highly detailed structures 
for amyloid fibrils [Makin et al., 2005; Nelson et al., 2005]. 
 
115 Å, 24 β-strands 
 
Figure 4: Molecular model of the common core protofilament structure of amyloid fibrils. A number of β-
sheets (four illustrated here) make up the protofilament structure. These sheets run parallel to the axis of 
the protofilament, with their component β-strands perpendicular to the fibril axis. With normal twisting of 
the β-strands, the β-sheets twist around a common helical axis that coincides with the axis of the 
protofilament, giving a helical repeat of 115.5 Å containing 24 β-strands (this repeat is indicated by the 
boxed region) [adapted from Sunde et al., 1997].    
 
1.5. Mechanism of amyloid fibril formation 
 
The most widely accepted and characterized mechanism of amyloid formation is 
the so-called “nucleation-elongation” or “nucleated growth” mechanism. Kinetic 
measurements of spontaneous aggregation usually show a lag phase, when no major 
changes are observed, followed by a rapid exponential growth phase [Nielsen et al., 
2001; Serio et al., 2000]. The lag phase is defined as the time, required for the formation 
of “nuclei” – the structures which are able to grow into amyloid fibrils. Once the 
nucleus is formed, the fibril starts to grow by the attachment of either monomers or 
oligomers to the nucleus.  
A lot of effort directed toward studying the nucleation process and the 
identification and characterization of the structures forming prior to fibrils has been 
made during the last decade. It has been shown that globular proteins need at least 
partial unfolding to be able to aggregate and form amyloid fibrils [Dobson, 1999; 
Uversky and Fink, 2004]. In some cases the presence of structured oligomers [Kayed et  
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Figure 5: A schematic representation of some of the many conformational states that can be adopted by 
polypeptide chains. The transition from β-structured aggregates to amyloid fibrils can occur by addition 
of either monomers or protofibrils (depending on the protein) to preformed β-aggregates. All of these 
different conformational states and their interconversions are carefully regulated in the biological 
environment, much as enzymes regulate all the chemistry in cells, by using machinery such as molecular 
chaperones, degradatory systems, and quality control processes. Many of the various states of proteins are 
utilized functionally by biology, including unfolded proteins and amyloid fibrils, but conformational 
diseases will occur when such regulatory systems fail, just as metabolic diseases occur when the 
regulation of chemical processes becomes impaired [Chiti and Dobson, 2006]. 
 
al., 2004; Quintas et al., 2001] or unstructured aggregates [Kishnan and Lindquist, 2005; 
Modler et al., 2003] has been reported. Polypeptide chains can adopt different 
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conformational states and interconvert between them on a wide range of timescales. The 
network of equilibria, which link some of the most important of such states both inside 
and outside the cell, is schematically illustrated in figure 5 [Chiti and Dobson, 2006]. 
 
1.6. Seeding 
 
A nucleated growth mechanism has been well studied in other contexts such as 
crystallization of molecules [Jarrett and Lansbury, 1993]. As in other processes 
dependent on a nucleation step, the addition of preformed fibrillar species to a protein 
sample under aggregation conditions causes shortening or complete elimination of the 
lag phase [Serio et al., 2000]. Such an effect is known as seeding. In the context of the 
nucleated growth model, the addition of preformed fibrillar species can be equated to 
addition of nuclei, so that the elongation process can start without the additional time 
(lag phase) required for the nuclei formation. In many cases, the formation of nuclei 
requires destabilization of protein; in the case of some familial forms of diseases it is the  
 
 
A 
B 
Figure 6: Under native conditions, the proteins are not able to form fibrils (A), but once preformed 
fibrillar species are added, elongation of fibrils occurs (B).  
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primary mechanism through which natural mutations mediate their pathogenicity [Canet 
et al., 2002]; but when preformed fibrillar species are added to a sample, elongation of 
fibrils can proceed even under conditions, which are normally not favorable for nuclei 
formation [Dzwolak et al., 2004a]. The ability of preformed amyloid fibrils to seed 
native proteins under native conditions (Fig. 6) opens a new page in the history of 
infectious particles by creating prions. 
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2. Materials and Methods 
 
2.1. Materials  
 
2.1.1. Chemicals 
 
Chemicals, used for the experiments presented in this work are described in the 
following table (Table 3). For all experiemnts deionized water with (> 18 MΩ cm) was 
used, being obtained with the aid of an ELGA PURELAB Classic polisher system 
(ELGA LabWater, Celle, Germany). 
 
Table 3: Chemicals, used for the experiments. 
 
Material Supplier 
 
Insulin from bovine pancreas 
Poly-D-lysine, 27.2 kDa (PDL)  
Deuterium oxide, 99.9 atom % D (D2O) 
Deuterium chloride, 99 atom % D (DCl) 
Ethyl alcohol-d, 99.5 atom % D (EtOD) 
Sodium deuteroxide, 99.5 atom % D (NaOD) 
Hydrochloric acid (HCl) 
Ethyl alcohol (EtOH) 
Sodium chloride (NaCl) 
Sodium phosphate, monobasic (NaH2PO4) 
Sodium phosphate, dibasic (Na2HPO4) 
Sodium hydroxide (NaOH) 
2,2,2-Trifluorethanol (TFE) 
Glycerol 
Thioflavin T (ThT) 
Chloroform (CHCl3) 
Islet amyloid polypeptide (IAPP) 
 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Merck, Darmstadt, Germany 
Sigma-Aldrich, Steinheim, Germany 
Merck, Darmstadt, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Merck, Darmstadt, Germany 
Merck, Darmstadt, Germany 
Sigma-Aldrich, Steinheim, Germany 
Merck, Darmstadt, Germany 
Merck, Darmstadt, Germany 
Calbiochem®, Merck, Darmstadt, Germany  
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2.1.2. Insulin 
 
Insulin is a hormone produced by β cells in the pancreas. It has three important 
functions: it allows glucose to pass into cells, suppresses excess production of sugar in 
the liver and muscles and suppresses the breakdown of fat for energy.  
Insulin is a rather small protein, with a molecular weight of 5740 Daltons. It is 
composed of two peptide chains, referred to as the A chain and B chain. The chains are 
linked together by two disulfide bonds, and an additional disulfide is formed within the 
A chain. In most species, the A chain consists of 21 amino acids and the B chain of 30 
amino acids (Fig. 7). 
 
B chain, Mw 3400Da             FVNQHLC GSHLVEALYLV CGERGFFYTPKA 
                              │              │ 
A chain, Mw 2340Da              GIVEQCCASVCSLYQLENYCN 
                           │_____│ 
Figure 7: Primary structure of bovine insulin. 
 
 Although the amino acid sequence of insulin varies among species, certain 
segments of the molecule are highly conserved, including the positions of the three 
disulfide bonds, both ends of the A chain and the C-terminal residues of the B chain. 
The similar amino acid sequences of insulin lead to similar three dimensional 
conformations of protein from different species, and the insulin from one particular 
animal is very likely biologically active in other species, as well. Indeed, pig insulin has 
been widely used to treat human patients.  
 
 
A B C 
Figure 8: A molecular model of bovine insulin. Monomer (A), dimer (B) and hexamer (C), with the A 
chain colored blue and the larger B chain green [from the Protein data bank (file name 2a3g), picture 
created using Biodesigner software]. 
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The secondary structure of insulin is predominantly α-helical. Insulin molecules 
have a tendency to form dimers in solution due to hydrogen-bonding between the C-
termini of the B chains. Additionally, in the presence of zinc ions, insulin dimers 
associate into hexamers (Fig. 8).  
The ability of insulin to form fibrils under certain conditions was reported in the 
middle of the last century [Waugh, 1946; Waugh et al., 1950]. After the discovery of 
prions, the interest in amyloid fibril formation increased and insulin became one of the 
most popular model protein for these studies. But despite these efforts, comprehensive 
mechanisms of insulin fibrillation are still lacking. 
 
2.1.3. Polylysine 
 
Polylysine is a synthetic polymer. There are two main reasons, for which 
polylysine is an excellent, probably even the simplest model for protein aggregation 
studies. It undergoes an α-helix-to-β-sheet transition, the hallmark of protein 
aggregation, and forms amyloid-like fibrils [Fuhrhop et al., 1987; Fändrich and Dobson, 
2002; Dzwolak et al., 2004c]. The sequenceless character of the polypeptide permits 
exploring of the hypothesis that aggregation is as a common generic feature of proteins 
as polymers taking place when native protein tertiary contacts are overruled by main-
chain interactions [Dobson, 2004]. 
 
2.1.4. Islet amyloid polypeptide (IAPP) 
 
IAPP (also known as amylin) is a 37 amino acid residue peptide hormone 
[Lorenzo and Yankner, 1994] that is co-synthesized and co-secreted with insulin by 
pancreatic β-cells [Cooper et al., 1989]. Several functions have been associated with the 
soluble form of this hormone [Cooper et al., 1989; Johnson et al., 1992], including the 
control of hyperglycemia by restraining the rate at which dietary glucose enters the 
bloodstream. For reasons that are still not fully understood, IAPP aggregates in the 
extracellular matrix of the β-cells forming fibrillar amyloid deposits. These deposits are 
present in approximately 95 % of type II diabetes mellitus patients and are strongly 
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associated with degeneration and loss of islet β-cells [Westermark and Wilander, 1978; 
Hayden, 2002]. 
It has been proposed that the IAPP aggregation process has two distinct phases: a 
lateral growth of oligomers followed by longitudinal growth into mature fibrils [Kayed 
et al., 1999; Padrick and Miranker, 2001, 2002; Green et al., 2004], and it has been 
demonstrated that the initial stages of IAPP fibril formation are driven by the increase 
of solvent-exposure of hydrophobicity patches [Kayed et al., 1999]. However, the 
structural changes behind the fibrillization process are still poorly understood. 
 
2.2. Methods 
 
2.2.1. Atomic Force Microscopy (AFM) 
 
All images were recorded on a MultiMode scanning probe microscope equipped 
with a Nanoscope IIIa Controller from Digital Instruments (Santa Barbara, California, 
USA). The microscope was coupled to an AS-12 E-scanner (13-µm) or J-scanner (100-
µm) and an Extender Electronics Module EX-II (Santa Barbara, California, USA), 
which allows for acquisition of phase images. Typically used AFM-probes were 
aluminum-coated NCHR silicon SPM sensors (force constant = 42 N/m; length = 125 
µm; resonance frequency ≈ 250-330 kHz; nominal tip radius of curvature ≤ 5 nm) from 
Nanosensors, Nanoworld or Budgetsensors. The AFM head with optical block and base 
was placed atop a commercially available active, piezo-actuated vibration-damping 
desk from Halcyonics (Göttingen, Germany). All measurements were done in the air 
using TappingMode™. 
TappingMode™ (Fig. 9) AFM operates by scanning a tip attached to the end of an 
oscillating cantilever across the sample surface. The cantilever is oscillated at or near its 
resonance frequency with amplitude ranging typically from 20 nm to 100 nm. The tip 
lightly “taps” on the sample surface during scanning, contacting the surface at the 
bottom of its swing. The feedback loop maintains constant oscillation amplitude by 
maintaining a constant root mean square of the oscillation signal acquired by the split 
photodiode detector. The vertical position of the scanner at each (x,y) data point in 
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order to maintain a constant "setpoint" amplitude is stored by the computer to form the 
topographic image of the sample surface. By maintaining a constant oscillation 
amplitude, a constant tip-sample interaction is also preserved during imaging. The 
operation can take place in either ambient or liquid environment. When imaging in air, 
the typical amplitude of the oscillation allows the tip to contact the surface through the 
adsorbed fluid layer without getting stuck [Scanning probe microscopy training 
notebook, Digital Instruments]. 
 
 
Figure 9: Scheme of AFM measurements using the TappingMode™ [adapted from the scanning probe 
microscopy training notebook, Digital Instruments]. 
 
Samples were diluted with deionized water to a final concentration of 0.5-2 µM, 
10-30 µl were applied onto freshly cleaved muscovite mica and allowed to dry.  
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2.2.2. Fourier-transform infrared spectroscopy (FTIR) 
 
The FTIR spectra were recorded using the Nicolet MAGNA 550, Nicolet NEXUS 
and Nicolet 5700 spectrometers from Thermo Scientific (Waltham, Massachusetts, USA) 
equipped with a liquid nitrogen cooled mercury-cadmium-telluride (MCT) detector. For 
all measurements, CaF2 transmission windows and 0.05 mm Teflon or Mylar spacers 
were used. The temperature in the cell was controlled through an external water-circuit. 
For each spectrum, 256 interferograms of 2 cm−1 resolution were co added. The sample 
chamber was continuously purged with dry air. From the spectrum of each sample, a 
corresponding buffer spectrum was subtracted. All the spectra were baseline-corrected 
and normalized prior to further data processing. The plots of the progress of α-helix–to–
β-sheet refolding upon aggregation were calculated as (I − Iα)/(Iβ− Iα), where Iα is 
spectral intensity at 1625 cm−1 (or 1622 cm−1 in EtOD) of the native insulin 
(corresponding to the first spectrum), Iβ is the intensity after complete aggregation, and I 
is a transient intensity at this wavenumber. All data processing was performed with the 
GRAMS software (Thermo Scientific).  
 
2.2.3. Ultrasonic resonator technology (URT) 
 
The ultrasonic measurements were carried out using an ultrasonic resonator 
device (ResoScan system, TF Instruments GmbH, Heidelberg) with ultrasonic 
transducers made of single-crystal lithium niobate of a fundamental frequency of 9.5 
MHz. The instrument comprises two independent cells for sample and reference with a 
path length of 7.0 mm. They are embedded into a metal block Peltier thermostat with a 
temperature stability of 0.001 °C. The resolution of the ultrasonic velocity 
measurements is 0.001 m s-1. Ultrasonic velocities of the sample (U) and reference 
solvent (U0) were measured over the same temperature range and at the same heating 
rate. 
The fundamental pre-condition for the propagation of acoustical waves in media is 
the elastic coupling of the molecules to the media. For example, in solid phase materials 
the atomic bodies are thought to be coupled via “spring-like bonds”, while in liquids 
and gases elastic collisions are conceptualized as coupling intervals. In the absence of 
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sound, all these building elements are equally spaced, so that the mean force on them 
vanishes. Once this system is disturbed by a sudden and stepwise move of a rigid wall, 
the building blocks next to this wall get compressed and due to the described coupling, 
this compression propagates with the speed of sound (Fig. 10). 
position x  
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vibrating 
wall
compressed
expanded
direction of 
displacements
 
Figure 10: A periodically vibrating wall generates a wave field (black lines) were the displacements ξ  of 
the building blocks results in areas of compressed and expanded density [Principles of sound 
measurement, TF Instruments].  
 
If the wall moves periodically at the position x=0, a uniform wave field is created, 
which means that at a fixed position x the same phase of motion is reached after the 
time period T. The reciprocal of the time period T is the frequency f, usually expressed 
in Hz. At a snapshot at a fixed time t the wave field has the same phase of motion at 
points separated by the wavelength λ (along the direction of propagation). The wave is 
mathematically described by a function ξ(x, t), which is the displacement of building 
blocks from the rest position at position x and time t. Wavelength λ and frequency f 
appear in this function as free parameters. Given the time period, T, for a propagation of 
a length, λ, the speed of sound can be found: 
 
 19
U=λ/T=λf         (1) 
U is a constant for any material, which depends on the coupling strength between 
the building blocks of the medium.  
The ResoScan system uses an acoustic resonator arrangement to measure the 
velocity of sound. The resonator consists of an ultrasonic sender and an ultrasonic 
receiver with the space between sender and transmitter filled with the sample fluid. A 
prerequisite for the high accuracy of measurements is the precise parallel alignment of 
sender and transmitter. Due to the reflection of sound at the transducers, a standing 
wave pattern can be established (Fig. 11A), but this is possible only at the ultrasonic 
wavelength λn, were the distance D between sender and receiver is (n is dependent on 
the standing wave pattern (Fig. 11B)): 
2
nλnD =          (2) 
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Figure 11: Establishing standing wave between transducers (A) and standing wave pattern for n=1, 2, 3 
and 73 (B) [adapted from Short training course, TF Instruments]. 
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On the other hand, the wavelength λ is linked to the frequency f, and the velocity 
of sound in liquid UL, which is a characteristic for each wave transporting medium (here 
the fluid) via relation (1). 
Since inside the resonator only standing waves with length λn are allowed, only 
discrete frequencies fn may exist: 
LUfλ nn =          (3) 
These frequencies fn are the real quantities to be measured by the Resoscan. This 
is done due to the fact that mostly the frequencies can be measured with high accuracy, 
while the length D of the resonator is held fixed and measured only once by the 
manufacturer.  
The combination of (2) and (3) yields the frequencies at which standing waves 
inside the resonator may exist: 
D
Unfn 2
L=          (4) 
In the terminology of ultrasonic interferometry, n is called the “peakorder”. For 
example for our Resonator of D=7 mm, UL=1498 m/s, one gets from (5) fn = n·107 kHz, 
which means the first resonance is at 107 kHz, the second at 214kHz, the 78th at 8.346 
MHz, etc.  (Fig. 12). The spacing between resonances is called the base frequency fL for 
the liquid:  
 
D
Ufff nn 2
L
1L =−= +         (5) 
The above-mentioned approach implies the determination of the velocity of sound 
by measuring the difference between adjacent resonances fn, as well as the length D of 
the resonator, followed by using (5) to calculate the velocity. 
However, under real experimental conditions, the measured sequence of 
frequencies does not have exactly the same spacing (5) (due to the influence of the 
natural frequency of the transducers, which is in the same range as the measured 
frequencies of the fluid resonances). Since it is not obvious which of the several 
spacings is to be considered for the determination of the velocity, this results in a large 
error of the velocity determination. 
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78 79
 
Figure 12: Schematic view of resonances in an ideal resonator with the dimensions of the ResoScan® 
System in the range from 8 to 9 MHz. Sample: water at 25.4 °C, U = 1498 m/s, D = 7.0 mm [Introduction 
into the Ultrasonic Resonator Technology, TF Instruments].  
 
A theoretical model of the resonator shows that, in the vicinity of the “natural 
frequency” of the ultrasonic transducers fR, significant deviations from the equal spaced 
model (4) exist. These deviations “yn” of the measured frequencies from the harmonic 
row (4) can be described by a simulation function yn: 
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where zL is acoustical impedance of the fluid, zR is acoustical impedance of the 
transducers, fR is natural frequency of the transducers and fn is measured frequency of 
order n. 
Fitting the simulation function (6) to the measured deviations of the observed 
resonances to the harmonic row delivers the parameters of the function. 
This method is used at the initial setup (at the manufacturer) of a new resonator, to 
determine for a fluid of known UL and zL, the following resonator-specific values: D, zR 
and fR. These parameters are fixed in the operating software. 
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Conversely, UL and zL of the investigated fluid can be determined with the already 
known parameters D, zR and fR of the resonator. This is done automatically during the 
initialization process of the operating software.  
After the initialization process of the device, the velocity of sound in the fluid as 
well as the correction for every resonator mode is known. Therefore it is appropriate to 
measure a single Resonator mode repeatedly with high accuracy, to follow the velocity 
of sound in the sample with respect to time or temperature. The single repeatedly 
measured mode is called the “Master Peak”. 
The measurement of this single Master Peak is done in a so-called “phase 
scanning mode”, were the resonator mode is sampled with very high accuracy. From the 
amplitude vs. frequency curve, a polynomial fit is done by the operation software to get 
the best value for the velocity of the sample [Principles of sound measurement, TF 
Instruments].  
 
2.2.4. Densitometry 
 
Density measurements were carried out with a DMA 58 density meter from Anton 
Paar (Graz, Austria) with a precision of ±5·10-5 g/cm3, or DMA 5000 from Anton Paar 
GmbH (Graz, Austria) with a precision of ±5·10-6 g/cm3.  
Both density meters determine the density ρ of liquids and gasses by measuring 
the period of oscillation. To this end, the sample is introduced into a system which can 
oscillate and whose “natural frequency” is influenced by the mass of the sample. This 
system is a U-shaped tube which is excited to undamped oscillations by electronic 
means. Both straight sections of the U-shaped tube form the spring element of the 
oscillator. The direction of the oscillation is perpendicular to the plane of the U-shaped 
tube. The oscillating volume V is limited by the mounting points which are fixed. If the 
oscillator has been filled with the sample at least up to the mounting points, then the 
same known volume V of the sample also oscillates. The mass of the sample can 
therefore be considered as proportional to its density. If the oscillator has been filled 
beyond the mounting points, this has no effect on the measurement. For this reason, the 
oscillator can also measure the densities of samples flowing through it. 
 
 23
Assuming that the temperature is held constant, the density can be calculated from 
the period by considering a hollow body with mass M suspended on a spring constant s. 
The volume V of the hollow body is then filled with a sample of density ρ. The natural 
frequency of this spring mass system is: 
VM
s
π
f ρ+= 2
1         (7) 
and the period T is: 
s
VMT ρπ += 2         (8) 
Density dependent on the period T is: 
V
M
V
sT −= 2
2
4πρ          (9) 
Using the abbreviations A=c/4π2V and B=M/V, we arrive at 
BAT −= 2ρ          (10) 
The constants A and B comprise the spring constant of the oscillator, the mass of the 
empty tube and the volume of the sample involved in the oscillation. A and B are 
therefore device constants for each individual oscillator. They can be derived from two 
period measurements when the oscillator has been filled with substances of known 
density [User manual, Anton Paar]. 
The partial specific volume of the protein has been calculated using 
cccv 0
o /)(/1 ρρ −−=        (11) 
ρ and ρ0 are the densities of the solution and solvent, respectively; c is the specific 
concentration of the protein.  
 
2.2.5. Differential scanning calorimtery (DSC) and Pressure perturbation calorimetry 
(PPC) 
 
DSC and PPC measurements were carried out on a VP DSC calorimeter from 
MicroCal (Northampton, MA) equipped with the MicroCal’s PPC accessory. For the 
DSC measurements, both cells of the calorimeter were first filled with buffer and a scan 
was performed. Immediately after the scan, the buffer was removed from the sample 
cell, replaced with ca. 0.5 mL sample and the measurement was performed. Buffer-
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buffer data were subtracted from sample-buffer data. The specific heat capacity of the 
protein at constant pressure has been obtained from 
o
00,
o //∆ vcvmCc ppp +=        (12) 
pC∆  is the heat capacity difference between the sample solution and solvent reference 
cell as obtained by a the measurement; and  are the partial specific volumes of the 
solute and solvent, respectively. 
ov o0v
For the PPC measurements, gas (N2) pressure jump applied to the samples was 5 
bars. Under the same experimental conditions, a set of reference sample-buffer, buffer-
buffer, buffer-water, and water-water measurements was carried out each time. The 
values of partial specific volumes used for volumetric calculations were obtained from 
density measurements. 
 
2.2.6. Fluorescence Spectroscopy 
 
Fluorescence measurements were carried out on a K2 multifrequency phase and 
modulation fluorometer (ISS, Urbana, IL). The measurements were performed within a 
high-pressure cell (ISS), equipped with sapphire windows, and the pressure was 
controlled by an automated pressure control system (APP, Ithaca, NY). 
Insulin and the fibril-specific dye Thioflavine T (ThT) were dissolved in H2O (pH 
1.9) at a final protein to dye molar ratio of 50:1. The emission intensity at 482 nm was 
recorded upon excitation at 450 nm as a function of time t. The data were normalized by 
dividing the intensity at every point to the intensity recorded for the final aggregates. 
 
2.2.7. Calculation of compressibilities 
 
The most accurate method of determining the partial molar compressibility, , 
of a solute is based on the Newton-Laplace equation, which relates the coefficient of 
adiabatic compressibility of a medium,  
o
SK
( )( )SS pVVβ ∂∂−= //1         (13) 
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with its density, ρ, and sound velocity, U [Gekko and Hasegawa, 1986,1989; Taulier 
and Chalikian, 2002; Chalikian, 2003]: 
          (14) 12 )( −= ρβ SU
For (infinitely) dilute solutions [Taulier and Chalikian, 2002; Chalikian, 2003], 
( )0o0oS /][22 ρβ MUVK S −−=       (15) 
where  
SS VK βoo =           (16) 
and 
pTnVV ,
o )/( ∂∂=          (17) 
is the partial molar volume of the solute, M its molar mass, and 
[U] = (U-U0)/(U0ּC)        (18) 
is the relative molar sound velocity (increment) of the solute; U and U0 are the sound 
velocities of the solute and solvent, respectively.  
Experimental data on 
oo /VKTT =β          (19) 
of proteins are very scarce as it is technically challenging to measure the partial specific 
volume as a function of the pressure using densimetric techniques with high precision 
[Seemann et al. 2001]. However, the partial molar isothermal compressibility of the 
solute can be obtained from the adiabatic value by [Taulier and Chalikian, 2002; 
Chalikian, 2003] 
( )( ))/(/2 )/( 00o0o0020oo pppST cCEcTKK ραρα −+=     (20) 
where cp0 is the specific heat capacity at constant pressure of the solvent, α0 is the 
coefficient of thermal expansion of the solvent, respectively, and 
          (21) pTVE )/(
oo ∂∂=
is the partial molar expansibility of the solute, which can be determined with high 
precision from pressure perturbation calorimetric measurements [Ravindra and Winter, 
2003; Schreiner et al., 2004].  is the partial molar heat capacity of the solute, and T 
is the absolute temperature. 
o
pC
 
 26
3. Results and discussion 
 
3.1. Insulin aggregation and amyloidogenesis 
 
3.1.1. Effect of co-solvents 
 
A 2% solution of insulin in D2O with 0.1 M NaCl (with or without 20% ethanol, 
TFE or glycerol), pD-adjusted to 1.9 was used (pH-meter readout +0.4 [Makhatadze et 
al., 1995]). The temperature was increased continuously at a rate of 20 ºC/h. 
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Figure 13: Time resolved FTIR spectra of insulin during heating and incubation at 60 ºC 
 
With the increase of temperature, the amide II band (1543 cm-1) decreases and 
amide II’ (1445 cm-1) increases because of H-D exchange (Fig. 13). Monitoring this 
process allows one to follow the exposure of the protein to the solvent, which is related 
to partial unfolding (Fig. 14). Experiments show that full H-D exchange in 20% ethanol 
is completed just below 45ºC, in 20% glycerol and in pure D2O at around 47ºC, and in 
20% TFE at about 50ºC. Ethanol seems to destabilize native α-helical structures of 
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insulin, TFE stabilizes them and glycerol seems to have no significant effect at this 
stage. 
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Figure 14: H-D exchange rate monitored in the presence of different co-solvents. 
 
A further increase in temperature and further incubation at 60 ºC leads to changes 
of the secondary structure, from α-helix to β-sheet, which is reflected in the decrease of 
the peak around 1650 cm-1 and the increase of the peak in the region between 1620-
1630 cm-1 of the amide I/I’ band (Fig. 13). The kinetics of aggregation under different 
conditions was monitored by plotting the relative extent of α/β-transition (Fig. 15). The 
presence of glycerol or TFE seems to stabilize α-helical structures, while the 
aggregation curve in the presence of ethanol shows similar a midpoint when compared 
with the one in pure D2O. The main difference is the faster rate of aggregation.  
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Figure 15: Aggregation kinetics of insulin monitored in the presence of different co-solvents 
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The final spectral positions of the amide I’ band depend on the presence of co-
solvents during the aggregation process (Fig 16). Amide I’ band positions are as follows: 
in case of 20% TFE – 1621 cm-1, 20% ethanol – 1622 cm-1, pure D2O – 1625 cm-1, and 
20% glycerol – 1626 cm-1. A red shift of the band suggests stronger interstrand 
hydrogen bonds in the aggregates formed in the presence of ethanol and TFE, while the 
small blue shift suggests weaker interstrand hydrogen bonds in the aggregates formed in 
the presence of glycerol. Similar observations have been reported previously for insulin 
amyloids grown in the presence of ethanol [Dzwolak et al., 2004] and acetic acid 
[Nielsen et al., 2004]. Taken together, the data suggests the ability of insulin to form 
different final amyloid structures starting from the same amino acid sequence. 
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Figure 16: Amide I’ band of final insulin amyloid aggregates in different co-solvents. 
 
3.1.2. Sonication of amyloid fibrils 
 
0.5 % insulin was dissolved in HCl, pH 2, and incubated for 40 hours at 60°C to 
induce formation of fibers (Fig. 17A). The sample was subjected to an ultrasonic bath 
(45 kHz, 30W) for different times. This leads to braking of fibers into shorter pieces 
(Figs. 17B and C). 
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A B C
E FD 
Figure 17: AFM pictures of insulin amyloid fibrils. Before sonication (A); after 30 min sonication (B); 3 
hours sonication (C); 24 hours (D), 72 hours (E) and 168 hours (F) incubation at room temperature.  
 
Sonicated fibers were kept at room temperature for a week to check if broken 
pieces could reconnect together. The process of fibrils sticking together is rather slow – 
there were no long fibrils found after 24 hours of incubation (Fig. 17D). Though further 
incubation leads to formation of colonies, including fibril-like particles (Fig. 17E) of a 
similar length as the fibrils have before sonication (Fig. 17A). A closer look at the AFM 
pictures shows that most of the broken fibrils stick together via their ends (Fig. 17F), 
suggesting that broken fibrils are probably more prone to attach additional particles and 
thus elongate. 
 
3.1.3. Seed induced aggregation 
 
The seed-induced aggregation of bovine insulin at pD 1.9 and 25°C was followed 
by time-resolved FTIR spectroscopy (Fig. 18A). The infrared spectra show a gradual 
shift of the amide I’ band to 1625 (in acidified D2O) or 1622 (acidified 20% (v/v) 
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ethanol in D2O) cm−1, accompanied by a marked narrowing of the peak, both of which 
reflect the complete transition of the native structure into nonnative aggregated β-
strands. The amyloidal character of the final insulin aggregates was confirmed by 
atomic force microscopy scans, which exhibit typical fibrils (Fig. 18B). 
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Figure18: Seeds-induced aggregation of insulin. (A) Time-dependent changes in FT-IR spectra show the 
gradual evolution of the amide I’ band of insulin reflecting the structural transition from the native form 
to amyloid: 2% (w/w) bovine insulin in 0.1 M NaCl in D2O, pD1.9, seeded at 25°C at a 20:1 weight ratio 
with preformed seeds. The total elapsed time between the first and the final spectrum was 20 h. Arrows 
show directions of the spectral changes. (B) A height-scan AFM image of the final insulin aggregate.  
 
 The position of the amide I’ band at 1622 or 1625 cm−1 is the fundamental 
spectral difference between insulin amyloids grown spontaneously (unseeded) at 60°C 
in the presence or absence of 20% (v/v) d1-deuterated ethanol (EtOD), respectively (Fig. 
19A). Although in either case, the band’s shapes and positions are characteristic for the 
amyloid’s parallel β-sheet structure, it is red-shifted for EtOD-grown samples (1622 
versus 1625 cm−1 for D2O-grown amyloid (Fig. 19A)). According to corresponding 
second derivative spectra (Fig. 19B), this shift should be specifically attributed to an 
increasing β-sheet fraction at 1620 cm−1. The mature amyloid fibrils do not exhibit any 
spectral changes after being resuspended in an alternative solvent (data not shown). 
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 Figure 19: The type of the original template determines the infrared spectral features of the grown 
amyloid. The amide I’ infrared band of insulin amyloids seeded homogeneously and heterogeneously. 
The original absorption FTIR spectra and 2nd derivatives (solvent/seed): D2O, 0.1 M NaCl in D2O (p 
D1.9); EtOD, 20% (v/v) EtOD in 0.1 M NaCl in D2O (pD 1.9).  
 
Insulin amyloid was seeded by mixing a small amount (5% (w/w) of the total 
protein content) of sonicated [Saborio et al., 2001] fibrils of either preparation with 
fresh insulin solution (either with or without 20% (v/v) EtOD). Should the insulin 
solution be the same as the one originally used for spontaneous growth of the seeds, this 
would be “homogenous seeding,” as opposed to the “heterogeneous seeding” with 
alternative amyloid fibrils type. The infrared spectra of each amyloid obtained through 
the homogenous seeding are very similar to the spectra of the spontaneously formed 
precursor seeds (Fig. 16). Minor differences are visible at ~1660 cm−1, namely, in the 
spectral region assigned to turns. Interestingly, templates of each type induce practically 
identical amyloid (in terms of its spectral features), when used for heterogeneous 
seeding (Fig. 19). This means that the critical factor, which determines spectral 
characteristics of growing amyloid is the preformed template, rather than the current 
solvent conditions. The FTIR data were subsequently used for plotting time 
dependencies of the amide I’ band position (Fig. 20A), its bandwidth at half height (Fig. 
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20B), and the relative change of the β-sheet content (Fig. 20C). The plots show that the 
spectral changes occur immediately after doping the native insulin with the amyloid. 
The fastest conformational transition takes place in the homogenously seeded ethanol-
containing insulin solutions. Apparently, each type of seed acts as a more effective 
catalysts in the insulin solution of its original growth. Figure 20, A and B, shows that 
both the peak position and bandwidth of the final amyloid depend on the seed, rather 
than the cosolvent. On the other hand, the presence of ethanol leads to a more 
pronounced (by roughly 2 to 3 cm−1) broadening of the amide I’ band at an intermediate 
stage of the aggregation process (Fig. 20B). The relative spectral intensity at 1625/1622 
cm−1 quantifies the actual amount of the aggregated β-strands (Fig. 20C). The plots 
calculated for the homogenously seeded amyloids show a linear time-dependent 
accumulation of the aggregated protein, and the other two corresponding to the 
heterogeneously seeded amyloids display some curvature. Especially, seeding insulin 
dissolved in 20% (v/v) EtOD with D2O-grown amyloids evokes a sigmoid-like shape of 
the corresponding curve in figure 20C.  
The second derivative spectra reveal that the EtOD type of amyloid has a higher 
fraction of the strongly hydrogen-bonded component of the β-sheet at 1620 cm−1. The 
different energy of the inter-β-sheet hydrogen bonding is likely to reflect subtle 
structural differences between the two types of fiber. The fact that the spectra of once-
formed amyloid remain intact after resuspending in another solvent, demonstrates that 
its spectrally distinguishable structural features are well conserved within the fiber. 
Furthermore, as protein aggregation is said to drive the protein molecules to the “real” 
global energy minimum, the fact that slow spontaneous aggregation results in 
particularly tuned β-sheet conformation suggests that, under given solvent conditions, 
this structure corresponds to such an energy minimum [Gazit, 2002]. The experiments 
with homogenous seeding have shown that, under conditions favoring particular 
amyloid structure and in the presence of seeds spontaneously formed under similar 
conditions, the growing amyloid will only maintain the fold of its initial template. 
Compared with the seeded aggregation at 25°C, the higher temperature (60°C) required 
for the spontaneous growth of amyloid appears to promote turns. Thus, it seems 
reasonable to attribute the presence of such less-ordered structural components to 
increased thermal fluctuations of the polypeptide chains, which are expected to hamper  
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Figure 20: Kinetics of the homogeneously and heterogeneously seeded aggregation of insulin at 25°C 
followed by the maximum of the amide I’ band (A), the amide I’ band’s width at half-height (HHBW; B), 
and the relative absorption of the spectral component assigned to β-sheets (C). 
 
an ideal packing of the insulin molecules within the fibrils. Interestingly, the 
heterogeneous seeding experiments concluded in figure 19 prove that a slightly altered 
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structure of the foreign seed is capable of changing the protein conformation by pushing 
it off the preferential aggregation pathway. 
Recent studies have shown evidence that the “strains” reflect multiple distinct 
conformations of the prion (e.g., human [Wadsworth et al., 1999], hamster [Peretz et al., 
2002], yeast [Chien and Weissman, 2001; Chien et al., 2003]). Both insulin amyloid 
types obtained from the single protein propagate, maintaining the original infrared 
features even under conditions favoring a different fold in the β-sheet fibers (Fig. 20A, 
B). In light of these facts, the two distinct conformations of insulin amyloid appear to 
have “strain”-like character. 
When comparing the kinetics of seed-induced aggregation of insulin in D2O and 
in 20% (v/v) EtOD, one must take into account that insulin dimers predominate in the 
former case [Whittingham et al., 2002], and the presence of ethanol promotes formation 
of monomers [Millican and Brems, 1994]. The water-grown seeds are more effective in 
insulin solutions containing dimers than in the presence of monomer-inducing ethanol, 
which sheds light on a possible mechanism of the aggregation. Namely, although (under 
different conditions) human insulin has been shown to aggregate through a monomeric 
intermediate [Ahmad et al., 2003], the cross-seeding kinetic data presented in figure 20 
would easily fit to an aggregation scenario involving two parallel pathways: through a 
monomer (preferential pathway in 20% (v/v) ethanol) or through a dimer (preferential 
pathway in water). A similar case of a protein capable of aggregating through a dimeric 
intermediate is transthyretin [Serag et al., 2001]. Nevertheless, other factors such as 
structural fluctuations may play a role in the controlling kinetics of amyloidogenesis. 
The relative intensity of the β-sheet spectral component plotted as a function of time 
quantifies the progress of the aggregation. The deviation from linearity observed for the 
heterogeneously seeded amyloids is puzzling. The sigmoidal shape of the plot 
corresponding to the aggregation of insulin in the presence of ethanol initiated with 
water-grown amyloid reflects an increasing rate of the structural conversion. It could be 
hypothesized that such an enhancing effect stems from newly formed second-generation 
amyloid gradually acquiring a higher affinity to the abundant monomeric substrate, 
therefore becoming a more effective aggregation catalyst in the EtOD solutions. The 
kinetic obstacles revealed in the heterogeneous seeding experiments remind one of 
barriers facing prion cross-species propagation [Chien and Weissman, 2001; Peretz et 
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al., 2002; Chien et al., 2003]. On the other hand, the time-dependent enhancement of the 
catalytic properties of foreign fibrils appears to parallel the observation that a 
heterogeneously seeded second generation of AApoAII(B) protein fibrils grown in vivo 
induced a faster and more severe disease in mice [Xing et al., 2002]. In other words, the 
sigmoidal shape of the α/β-transition curve in EtOD/D2O-seed aggregation is likely to 
mirror refining catalytic properties of the growing amyloid. Despite these changes, the 
final FT-IR spectra continue to reflect the initial template (Fig. 19). 
Figure 20B depicts time-dependencies of the amide I’ bandwidth, which is a 
yardstick of structural fluctuations of a protein molecule. Increasing conformational 
fluctuations, which lead to disorder and unfolding of a protein, result in a marked 
broadening of the amide I’ band [Dzwolak et al., 2003]. By the same token, a reversed 
process of protein folding and subsequent assembling of native monomers into a 
compact and stable quaternary structure is expected to reduce, or simply damp, the 
fluctuations, leading to a narrowing of the band. This has been confirmed in a very 
recent Raman spectroscopic study, which specifically coupled narrowing of the amide I 
band to the damping of conformational fluctuations in insulin molecules, upon their 
assembly into higher oligomers, as well as a result of amyloid formation [Dong et al., 
2003]. Figure 20B shows that the aggregation initially causes broadening of the amide 
I’ band up to 57 cm−1, which should be attributed to the spectral separation between the 
transiently coexisting native α-helices and β-sheet. However, it seems quite likely that 
partly unfolded aggregation-intermediate states contribute to the broadening of the 
spectral band as well [Ahmad et al., 2003]. The EtOD-grown seeds render the final half 
height bandwidth (HHBW) larger by ~5 cm−1, suggesting a sustained degree of 
conformational fluctuations in the fibrils. 
 
3.1.4. Aggregation and seeding under high pressure 
 
To study insulin aggregation and seeding under high hydrostatic pressure we used 
a thermostated high pressure chamber for the incubation of samples and transmission 
FTIR spectroscopy for determining the secondary structures before and after incubation. 
0.5 % insulin solution in D2O, pH 2 (from now on pH in D2O solutions means pH-meter 
readout), containing 0.1 M NaCl, were incubated at two different temperatures, 25°C 
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and 60°C, and at two different pressures, 1 bar and 1000 bar in the absence and 
presence of 5% sonicated seeds, respectively (Fig. 21). 
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Figure 21: FTIR spectra of insulin structures in the absence (A) and presence (B) of seeds after 24 hours 
incubation at different temperatures and pressures. Red color represents 1 bar pressure and 25°C, green – 
1000 bar and 25°C, blue – 1 bar and 60°C, and black – 1000 bar, 60°C. Inserts show the 2nd derivative 
FTIR spectra of the final aggregates.  
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Figure 21A shows predominantly α-helical structure (amide I’ band maximum at 
1650 cm-1) after 24 hours incubation at 25°C, not much different from the sample kept 
under 1000 bar pressure, and dominant β-sheet structures after incubation at 60°C. 
Contrary to previous data of high pressure FTIR, using a diamond anvil cell [Dzwolak 
et al., 2003], β-sheet-rich aggregates were formed under 1000 bar pressure too. The 
final spectra of the samples at 60°C are very similar under ambient and high pressure 
conditions, both showing the same two types of β-sheet, represented by an amide I’ 
band maximum around 1628 cm-1 and a shoulder around 1615 cm-1, respectively, with 
just a bit broader peak in the case of 1000 bar pressure.  
Figure 21B shows β-sheet rich structures in each of the different conditions used. 
The final spectra at each temperature and pressure conditions are very similar, showing 
an amide I’ band maxima around 1625 cm-1, with the second derivative showing two 
minima around 1630 cm-1 and 1619 cm-1, respectively. During the process of sonication 
strong hydrogen bonds (1615 cm-1) of spontaneously formed β-structures are partially 
destroyed (Fig. 22) and the new bonds formed in the process of fibril elongation are 
weaker (1619 cm-1). That is the reason for the differences found in the spectra of 
spontaneously formed and seed-induced insulin amyloid. 
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Figure 22: FTIR spectra (A) and corresponding 2nd derivative spectra (B) of insulin fibrils before (solid 
line) and after (broken line) sonication. 
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In order to check if high pressure changes the seeding kinetics, fluorescence 
spectroscopy measurements were performed. 0.5 % insulin solution in H2O, pH 2, in the 
presence and absence of 0.1 M NaCl, respectively, were mixed with Thioflavine T 
(ThT), 5% seeds were added and samples were incubated at 37°C (this temperature was 
chosen due to the aggregation being too fast at 60°C and too slow at 25°C), 
continuously measuring the emission at 482 nm.  
Figure 23 shows the impact of pressure on the kinetics of seed-induced insulin 
aggregation. In the presence of salt (Fig. 23A), the application of higher pressures 
seems to increase the initial rate of elongation. The rate of aggregation at ambient 
pressure is constant (~linear increase) until around 80% of the insulin is aggregated, and 
then it levers off due to shortage of substrate. At higher pressures the initial rate is much 
higher and no linear behavior of the growth rate is observed. Such behavior may be 
explained by the higher reactivity in the pressure-assisted aggregation process. In the 
absence of salt (Fig. 23B) the process of aggregation is much longer and differences 
between ambient and high pressure are hardly seen.  
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Figure 23: Kinetics of seed induced insulin aggregation at different pressures in the presence (A) 
and absence (B) of 0.1 M NaCl. 
 
3.1.5. Compressibility of amyloid 
 
From the thermodynamic standpoint, the partial protein volume and its 
temperature and pressure derivatives, as well as enthalpy and volume fluctuations are 
the parameters determining protein stability, unfolding and aggregation behavior. These 
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parameters can be monitored by differential scanning (DSC) and pressure perturbation 
(PPC) calorimetry, densitometry and ultrasound velocimetry [Gekko and Hasegawa, 
1986, 1989; Taulier and Chalikian, 2002; Chalikian, 2003].  Through such a 
combination of methods a detailed thermodynamic description of an aggregating protein 
can be obtained, linking its thermodynamics to the generic behavior of proteins 
implicated in conformational diseases. Samples were prepared by dissolving insulin in 
H2O at 2 wt % concentration. The pH of the sample was adjusted to 1.9 with diluted 
HCl.  
Recently, molecular fluctuations of proteins and their coupling to the surrounding 
solvent have been receiving much interest [Fenimore et al., 2002]. Protein fluctuations 
permit conformational motions, such as flips of side chains and backbone motions, 
facilitating transitions between various substates. As the volume, enthalpy and electrical 
dipole moment fluctuations in the hydration shell and of the exposed amino acid 
residues are coupled to the surrounding solvent, the term "slaving" has been coined 
[Fenimore et al., 2002]. Thus the solvent emerges as an active participant in protein 
dynamics and folding. The fluctuations are given by the relevant susceptibilities, the 
specific heat capacity cp at constant pressure, and the isothermal compressibility, βT: 
pcmTkH  )∆(
2
B
2 = ,        (22) 
TVTkV β )∆( B2 = .         (23) 
Here, kB is the Boltzmann constant and V and m are the volume and mass of the 
protein, respectively. Combined enthalpy and volume fluctuations are related to the 
coefficient of thermal expansion [Cooper, 1984]: 
 .       (24) αVTkVH 2B )∆)(∆( =><
Volume fluctuations are a yardstick of protein flexibility, further related to its 
packing, void volume and solvational properties, and, in the end, to its biological 
function. On the several stages of the transition from the native state to the 
amyloid - destabilization, unfolding, aggregation, fibrillation -, volume fluctuations are 
expected to play a significant role [Dzwolak et al., 2004b; Grudzielanek et al., 2005] 
and are therefore discussed in this study.  
Typically, small or negative values of βS are obtained for the acid-, base- or 
guanidinium hydrochloride-induced denaturation processes of proteins [Gekko and 
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Hasegawa, 1986, 1989; Taulier and Chalikian, 2002; Chalikian, 2003]. The existing 
data have indicated that the compressibility of a protein can be divided into at least two 
components of opposite sign. Because of compressible cavities and voids in the protein 
interior, a first component is the protein intrinsic compressibility, βS,intr, which is 
positive. The second term, βS,hyd, is the contribution to the compressibility due to 
hydration and bound water. As the compressibility of single amino acids and small 
peptides in solution is negative [Gekko and Hasegawa, 1986, 1989; Taulier and 
Chalikian, 2002; Chalikian, 2003], βS,hyd is negative.  
Calculations of the volume fluctuations of the system by using expression (23) 
implies that V is the actual intrinsic volume of the protein, which represents the 
geometric volume of its solvent-inaccessible interior, and βT is the actual coefficient of 
isothermal compressibility of the protein interior [Chalikian, 2003]. This equation 
cannot be directly used for computing partial molar volume or compressibility data as 
determined here, because these still contain hydrational contributions. However, 
qualitative conclusions can be drawn. 
The actual aggregation of insulin is preceded by an endothermic unfolding of the 
native protein around 50 oC, which is accompanied by complete H/D exchange 
[Dzwolak et al., 2003]. In the native state, vo and the apparent coefficient of thermal 
expansion, α, show the typical temperature dependence of a native protein. Around 50 
oC, in the pretransitional range, α increases slightly and decreases significantly again 
above ~60 oC, when the aggregation of the protein sets in (Fig. 24A). These 
observations are in good agreement with previous PPC data suggesting that the abrupt 
decrease of α  upon aggregation is directly related to the release of water from shrinking 
solvent accessible surface area (SASA) of the fibrillating protein [Heerklotz, 2004; 
Dzwolak et al., 2004]. The initial increase of α points to a minor conformational change 
of the protein, accompanied by a slight increase of the solvent accessible surface area 
and hydration, both factors known to contribute to a positive α.  
Whereas βS does not change markedly with temperature, βT increases steadily up 
to ~50 oC, where a slight change in the slope is visible. The increasing isothermal 
compressibility data and hence mean square volume fluctuations may result from an 
increased imperfect packing of the amino acid residues and the dynamic character of a 
partially destabilized polypeptide. No drastic increase of βT is observed in the 
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pretransition region, which indicates that no expanded protein conformation is formed 
in this temperature range, which would lead to a significant increase in βT value [Mitra 
et al., 2006; Ravindra et al., 2004]. Also the PPC data point to a slight change in ASA 
and hydration of the protein, only. Upon unfolding and during the initial aggregation 
step at 60 oC,  and βov T decrease slightly with respect to the initial linear temperature 
dependence of vo and βT, respectively. The character of the temperature-dependencies of 
α and βT in the pre-aggregation period can be easily reconciled with the topological 
properties of the early, aggregation competent intermediates, which are bulky, solvent-
exchanged, and as yet are lacking any defined morphological motifs [Jansen et al., 
2005].  
Figure 24B presents the thermodynamic properties measured as a function of time, 
i.e., under the conditions when the time-dependent aggregation and fibrillation are 
taking place. These molecular processes result in significant changes in all the measured 
physicochemical properties, which are associated with formation of fibrillar topologies 
by the orderly-stacking insulin molecules [Jansen et al., 2005]. The data presented in 
this figure conveys a coherent picture of a "volumetric" catastrophe, which accompanies 
the amyloidogenesis: volume collapse, abrupt reduction of area of the protein-water 
interphases, and the simultaneous decrease of the compressibility of the protein. The 
drastic decrease of vo with time can be ascribed to a decrease of void volume. 
Furthermore, also the ASA and the hydration contribution diminishes, which are known 
to render α smaller. Also βT decreases substantially over the first 100 min of 
aggregation, indicating that the mean square volume fluctuations, which are highest at 
the early stage of the aggregation reaction, are drastically damped when the aggregation 
and fibrillation process proceeds. Upon subsequent aggregation and formation of mature 
fibrillar aggregates, as indicated by the Fourier transform FT-IR spectroscopic data 
acquired under corresponding sample conditions and heating regimes [Dzwolak et al., 
2003], significant dehydration and compaction occurs, whereby water molecules at the 
protein surface are released, rendering , α,  βov S and βT values constant after 150 min. 
The combined contributions of enthalpy and volume fluctuations, , as 
revealed by α, increases by ~ 2 % at the pretransition, and decreases overall by about  
 )∆)(∆( >< VH
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A B
Figure 24: (A) Results from measurements of the ultrasound velocity, specific protein volume, thermal 
expansion coefficient, adiabatic compressibility βS and isothermal compressibility βT of insulin as a 
function of temperature. (B) Results from measurements of the ultrasound velocity, specific protein 
volume, thermal expansion coefficient, adiabatic compressibility βS and isothermal compressibility βT at 
60 °C as a function of time. 
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30% during the aggregation and fibrillation process, the reduction in volume 
fluctuations being ~7%. The tight packing of β-sheets and depletion of internal cavities 
in the late fibrillar aggregates leads to a compaction and hence ~ 3% reduction of the 
final value of the partial specific protein volume. The decrease in solvent accessible 
surface area is also reflected in the negative Cp change of -2 kJ mol-1 K-1 as determined 
by DSC, recently [Dzwolak et al., 2003]. 
In comparison to βS, βT is always more positive above and below the transition 
point and displays a more pronounced temperature dependence in the α-to-β transition 
region. The larger magnitude and changes of βT may be attributed to the additional 
contribution of slower structural relaxation processes compared to βS, which essentially 
reflects fast (e.g., hydrational) relaxation processes. The slow structural relaxation 
processes detected by βT in the transition region may be due to structural relaxation 
processes of the highly flexible and dynamic transient oligomeric and smaller aggregate 
entities, and cease upon maturation of fibrils. Rather large differences in  β values are 
also observed at low temperatures, before unfolding and aggregation sets in. Such 
behavior may be due to the large contribution of slow relaxation processes in 
combination with monomer-dimer and dimer-oligomer equilibria shifting with 
increasing temperature.  
 
3.1.6. Impact of NaCl on aggregation 
 
To study the impact of salt, a 0.5 % insulin solution in D2O, pH 2 with and 
without 0.1 M NaCl was used. Samples were incubated at 60°C, simultaneously taking 
FTIR spectra every 5 minutes. 
The aggregation process is accompanied by the conversion of the native α-helical-
rich secondary structure to a β-sheet-rich structure within the amyloid fibril. This 
conversion finally gives rise to a prominent FTIR band at 1627 cm-1, characteristic for 
parallel-stacked, intermolecular β-strands [Bouchard et al., 2000], which develops 
progressively with time. The kinetic data (Fig. 25) show clearly that, in the presence of 
0.1 M NaCl, this process proceeds via an observable intermediate phase. The 
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intermediate phase vanishes when NaCl is absent, and the overall aggregation is by far 
slower and follows a simple sigmoidal time-course.  
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Figure 25: Degree of α/β-transition of insulin, kept at 60 °C (data derived from FTIR spectra). 
 
 
Figure 26: AFM images of insulin aggregates in presence of 0.1 M NaCl. Amorphous aggregates (or 
oligomers) formed after 35 min (left) and amyloid fibrils formed after 2 hours (right) of incubation at 60 
°C. 
 
Figure 26 shows atomic force microscopy images of the insulin species that have 
formed after incubation at 60 °C for 35 min and for 120 min, i.e., within the pre-
transition region and at the end of the main transition in the temporal FTIR profiles, 
respectively. The image after 35 min shows small amorphous aggregates (or oligomers) 
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besides coagulated elongated structures. The elongated species are of about 1 nm in 
height and consist largely of spherical particles that are attached to each other. 
According to the hierarchical assembly model for amyloid fibrils [Khurana et al., 2003], 
these resemble precursors of protofilaments. However, it is questionable whether these 
species transform directly into protofilaments or whether they have to dissociate first to 
re-enter the amyloid pathway. In contrast, after 120 min, a network of fibrillar species is 
observed. The fibrillar species appear as straight rod-like objects with varying lengths 
up to several micrometers and heights between approximately 3 and 10 nm. The former 
value corresponds to mature insulin fibrils, and the latter corresponds to laterally twisted 
coils of fibrils [Khurana et al., 2003]. 
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Figure 27: The second derivative FTIR spectra reflect insulin aggregation at 60 °C in the absence (left) 
and presence (right) of 0.1 M NaCl. 
 
A closer inspection of the amide I’ region of the second derivative FTIR spectra 
(Fig. 27) reveals at least two modes of intermolecular β-strand hydrogen bonding. In the 
absence of 0.1 M NaCl, a major band at 1627 cm-1 develops progressively, 
accompanied by the simultaneous appearance of a minor component at 1617 cm-1. The 
increase of the latter band, however, does not proceed beyond approx. 4 h. In contrast, a 
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single low-frequency band develops at 1619 cm-1 in the presence of 0.1 M NaCl within 
40 min, i.e., within the pretransition time-range. During the subsequent main 
aggregation transition, this band shifts slightly, to 1617 cm-1, and reduces in favour of a 
higher frequency band developing at 1627 cm-1, which dominates the spectrum of the 
completely aggregated, matured sample. 
The amide I’ band arises mainly from the carbonyl stretching vibration of the 
protein backbone amide groups, the frequency of which correlates with the strength of 
the hydrogen bonds these groups are involved in [Krimm and Bandekar, 1986]. We may 
refer to the low-frequency band as “strongly hydrogen bonded” amide groups and to the 
band at 1627 cm-1 as “weakly hydrogen bonded” amide groups. According to our data, 
relatively strong, but presumably few, hydrogen bonds are formed during the pre-
transition in 0.1 M NaCl. The formation of these bonds likely reflects the struggle of 
partially unfolded insulin monomers to saturate “dangling” hydrogen bonds [Thirumalai 
et al., 2003], which is feasible upon their electrostatically and hydrophobically driven 
assembly to non-native oligomers. On the other hand, amyloid nucleus formation and 
subsequent growth are accompanied by a substantial structural rearrangement into 
extended β-strands within the growing fibril. Owing to the rigidity of mature fibrils, 
intra-fibrillar hydrogen bonds are thought to underlie considerable geometrical 
constraints, especially within twisted fibrillar structures. Such constraints would be 
reflected in weakened hydrogen bonds that manifest in the high-frequency FTIR band at 
1627 cm-1. In fact, the frequency of the prominent β-sheet FTIR band for fibrils has 
been shown to correlate partly with the twist angle of the β-sheet, in that higher twist 
angles give rise to higher FTIR frequencies [Zandomeneghi et al., 2004]. 
We showed that 0.5% insulin pH 2 in the presence of 0.1M NaCl can aggregate in 
two steps, first forming amorphous aggregates and later amyloid fibrils while in the 
absence of salt direct fiber formation can be observed [Grudzielanek et al., 2006]. But 
neither FTIR, or fluorescence spectroscopy, nor AFM were able to tell much about 
physical properties of the aggregates. To get a deeper insight into differences in the 
process of insulin aggregation in the presence and absence of 0.1M NaCl, simultaneous 
measurements using FTIR spectroscoy, URT, densitometry and DSC were performed. 
To minimize time differences in aggregation times, due to the use of different 
measuring cells, volumes, and environmental conditions (e.g., weak ultrasound in URT 
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or tube vibration in the densitometer), the measurements were performed as temperature 
scans increasing the temperature from 25 to 85°C at a rate of 20°C/h. 
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Figure 28: Amide I/I’ region of FTIR spectra of 2% insulin in D2O, pH 2, in the presence (A) and absence 
(C) of 0,1 M NaCl at different temperatures.  B and D show second derivatives of these spectra. Blue 
lines are for 25°C, green lines for 65°C and red lines for 85°C. 
 
The FTIR measurements (Fig. 28) reveal very similar initial spectra at 25°C with 
a maximum at 1653 cm-1 (minimum of 2nd derivative at 1656 cm-1), which is typical for 
α-helical structures. The last spectra at 85°C also does not differ significantly; they 
show a maximum at 1628 cm-1 (minimum of 2nd derivative at 1628 cm-1 with a weaker 
one at 1619 cm-1) in the presence of 0.1 M NaCl and a slightly broader peak at 1627 cm-
1 (minimum of 2nd derivative at 1628 cm-1 with a weaker one at 1618 cm-1) in its 
absence – both cases are typical for β-sheet rich secondary structures. The main 
difference is hidden in between. In the absence of NaCl, the spectrum at 65°C shows a 
maximum at 1648 cm-1 together with a broadening of the band (no pronounced minima 
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in the 2nd derivative), which shows the unfolding of the protein to a random coil 
secondary structures. Conversely, in the presence of salt we can see a completely 
different picture: a broad β-sheet peak with the maximum between 1620-1628 cm-1 (the 
main minimum of the 2nd derivative is at 1619 cm-1 with a weaker one at 1628 cm-1) 
with a large broad shoulder within the range, characteristic for random coil secondary 
structures. All these spectra are comparable to the data of insulin aggregation at 60°C 
temperature, thus we can state, that the spectrum at 65°C in the presence of NaCl 
represents nonfibrillar aggregates (or oligomers) as found in AFM images, and both 
spectra at 85°C represent amyloid fibrils.  
Further processing of the FTIR spectra allow to follow the relative changes of β-
sheet rich structures with increasing temperature. Figure 29A displays the formation of 
preliminary aggregates, which takes place between 55 and 60°C, the lifetime of these 
aggregates between 60 and 75°C, and the formation of fibrils between 75 and 80°C in 
the presence of NaCl, respectively. Figure 29B shows a minor increase between 55 and 
70°C, which is mainly caused by H-D exchange and a broadening of the band due to of 
protein unfolding, and subsequent formation of fibrils between 70 and 80°C in the 
absence of NaCl. Calorimetric measurements show that both the processes of 
preliminary aggregation in presence of salt (positive peak between 55 and 60°C (Fig. 
29C)) and the unfolding in absence of salt (broad positive peak between 50 and 70°C 
(Fig. 29D)) are endothermic, whereas the following formation of fibrils (sharp negative 
peak between 75 and 80°C in presence of salt (Fig. 29C) with a negative peak between 
70 and 85°C in absence of salt (Fig. 2D)) is exothermic.  
Measured partial specific volumes together with sound velocity allow estimation 
of the partial adiabatic compressibility. The formation of nonfibrillar aggregates in the 
presence of NaCl leads to a small decrease in sound velocity (Fig. 29G) together with 
an increase in partial specific volume (Fig. 29E), which means a positive change in the 
partial adiabatic compressibility. As these preliminary aggregates occupy a larger 
volume than the native protein and are easier to compress, application of pressure 
should be able to prevent formation of such aggregates and should be able to dissociate 
them, in good agreement with recent pressure-dependent experiments [Grudzielanek et  
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Figure 29: Relative increase in β-sheet structures derived from FTIR spectra (A and B), measured specific 
heat capacity (C and D), partial specific protein volume (E and F) and sound velocity (G and H) in the 
presence (left column) and the absence (right column) of 0.1 M NaCl.  
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al., 2006]. The formation of fibrils leads to a decrease of the partial specific volume and 
an increase in sound velocity, reflecting a negative change in partial adiabatic 
compressibility. It seems that the fibrils are much denser and less compressible than the 
intermediate aggregates. Minor fluctuations of the sound velocity between 65 and 70°C 
(Fig. 29H) together with a decrease in partial specific volume (Fig. 29E) result in a 
negative change of  the partial  adiabatic  compressibility,  which  is  common  for  
protein  unfolding  [Chalikian et al., 1996]. Final fibrils occupy a comparable volume to 
the unfolded protein but the speed of sound is lower, which is due to a slightly higher 
compressibility. 
Following the data for both samples (with and without NaCl), we can see that 
most of the differences in the mechanisms of aggregation take place before the start of 
fibril formation. Formation of nonfibrillar aggregates in one case and unfolding in the 
other one reflects the differences seen in the data obtained through each single 
technique. Putting the data together, we can become more certain of how the process is 
proceeding. No single technique was able to confirm the formation of stable nuclei, 
which should form before growing of fibrils according to the nucleation-elongation 
hypothesis. Before the final part of fibril formation is reached we observed two different 
pathways – via partially unfolded nonfibrillar aggregates (or oligomers) in the presence 
of NaCl and via partially unfolded (or possibly full unfolded) monomers or dimers in 
the absence of salt. 
Differences in the process of fibril formation are not so well visible in most of 
experiments. FTIR data suggest similar secondary structure of the final fibrils, DSC 
suggests both processes being exothermic (with the only difference of a broader peak in 
the absence of NaCl, which could be due to a slower process). A fast decrease of the 
partial specific volume at the start of fibril formation, followed by an increase during 
the subsequent aggregation process was also observed in both samples. Such an 
unexpected behavior can be explained by the formation of very densely packed nuclei, 
followed by elongation of fibrils, which leads to a lower water accessible surface area 
and an increase of partial volume due to decreased hydration. The only technique, able 
to show such a significant difference in fibril formation between the samples, was URT. 
A large increase in sound velocity during fibril formation in the presence of NaCl leaves 
no doubts about the existence of different mechanisms of fibril formation, when 
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compared to the sample without salt, which shows a decrease in sound velocity upon 
forming fibrils, only. 
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Figure 30: Proposed scheme for the temperature dependent insulin aggregation process in the presence 
and absence of salt, respectively. 
 
The combined data from FTIR, URT, densitometry and DSC allows a proposal of 
the scheme for the temperature dependent insulin aggregation process in the presence 
and absence of 0.1 M NaCl (Fig. 30). We propose that in the absence of salt, insulin 
starts to unfold with increasing temperature, and, after reaching a certain level of 
unfolding (with dominating random coil secondary structure), it is able to form nuclei 
and grow into fibrils. In the presence of 0.1 M NaCl, insulin also partially unfolds (the 
fraction of random coil secondary structure is below 50%) with raising temperature, but 
around 55-60°C the protein forms partially unfolded nonfibrillar aggregates (or 
oligomers). Further increase of temperature leads to the formation of nuclei and growth 
of elongated fibrils. 
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Nuclei, formed from amorphous aggregates and final mature fibrils, formed in the 
presence of NaCl tend to stick together, which often causes problems in finding separate 
fibrils in AFM pictures (Fig. 31). 
 
A B
 
Figure 31: AFM pictures of typical insulin amyloid fibrils formed in the presence (A) or absence (B) of 
0.1 M NaCl. 
 
3.2. Thermodynamic properties underlying the α-helix-to-β-sheet transition, 
aggregation, and amyloidogenesis of polylysine 
 
Samples were prepared by dissolving the polypeptide in H2O at 2 wt % 
concentration. The pH of the sample was adjusted to 11.6 with diluted NaOH. 
Simultaneous measurements of the partial molar volume, the heat capacity, and the 
coefficients of thermal expansion, adiabatic and isothermal compressibility of the 
polylysine upon unfolding and aggregation, were performed (Fig. 32) 
Recently, it was shown using DSC (Fig. 32B), PPC, and circular dichroism (CD) 
spectroscopic measurements [Dzwolak et al., 2004c] that the α/β-transition in poly-D- 
and poly-L-lysine starts at ~35 °C and is completed at 50 °C. As revealed by the 
increase of the specific protein volume and the isothermal compressibility (Fig. 32D), a 
temperature-induced destabilization of the polylysine’s structure occurs just (~3 °C) 
before the onset of the unfolding and aggregation process. The increased isothermal 
compressibility data and hence mean-square volume fluctuations may result from an 
increased imperfect packing of the amino acid residues and the dynamic character of a 
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partially destabilized polypeptide, which is reminiscent of a molten globule kind of 
intermediate state, which has been shown to lead to a significant increase of 
compressibility values [Chalikian and Breslauer, 1996, 1998; Chalikian et al., 1996]. 
Upon unfolding and during the initial aggregation step, ν°, βS, and, most drastically, βT 
decrease simultaneously, reaching minima around 35 °C. This can be ascribed to a 
release in void volume and – probably more importantly – an increased hydration of the 
protein surface, which is known to render βS negative. Generally, the higher the total 
solvent-accessible surface area, the more negative is the hydration contribution. Hence,  
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Figure 32: Results from measurements of the (A) ultrasound velocity, (B) heat capacity, (C) specific 
protein volume, and (D) adiabatic compressibility βS and isothermal compressibility βT of a 2 wt % 
polylysine solution at pH 11.6 as a function of temperature. 
 
the mean-square volume fluctuations increase slightly before the onset of the 
unfolding/aggregation reaction and then decrease drastically in a rather cooperative 
manner when the unfolding and aggregation process sets in. Upon subsequent 
aggregation and formation of mature fibrillar aggregates, as indicated by the CD and 
FTIR spectroscopic data [Dzwolak et al., 2004], significant dehydration occurs, 
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whereby more densely packed water at the protein surface is released, leading to an 
increase of ν°, βS, and βT again, which, at higher temperatures, are largely determined 
by the thermal volume effect [Chalikian and Breslauer 1996, 1998; Chalikian et al. 
1996]. The large increase of βT just after the transition (at ~38 °C) indicates that the 
early aggregates formed (which might well be still partially amorphous) still undergo 
large volume fluctuations, which rapidly decay upon formation of larger fibrils. The 
tight packing of β-sheets and depletion of internal cavities in the late fibrillar 
aggregatesleads to a compaction and hence 20% reduction of the final value of the 
partial specific protein volume. The decrease in solvent-accessible area is also reflected 
in the negative Cp change of -4 kJ mol-1 K-1 (Fig. 32B). In comparison to βS, βT is 
always slightly more positive above and below the transition and displays drastically 
more pronounced temperature dependence in the transition region, however. The larger 
changes of βT may be attributed to the additional contribution of slower structural 
relaxation processes compared to βS, which essentially reflects fast (hydrational) 
relaxation processes only. The slow structural relaxation processes detected by βT in the 
transition region may be due to structural relaxation processes of the highly flexible and 
dynamic transient oligomeric and smaller aggregate entities. 
 
3.3. Islet amyloid polypeptide (IAPP) 
 
3.3.1. Effect of high hydrostatic pressure (HHP) 
 
So far, there are no reports regarding the effects of HHP on IAPP. Owing to the 
fact that high hydrostatic pressure acts to disfavour hydrophobic and electrostatic 
interactions that cause protein aggregation, this parameter can be used as efficient tool 
to reveal new important information on the nucleation and growth processes of the 
protein. High-pressure coupled with Fourier-transform Infrared spectroscopic studies 
and atomic force microscopy measurements were carried out to reveal the changes in 
IAPP aggregate and fibril formation under pressure-perturbation. 
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For the samples before and after pressure treatment, we used 10 mM NaH2PO4 
with 1 % residual TFE in D2O at pH 7.4 and a protein concentration of 250 µM (~0.1 % 
w/w). 
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Figure 33: FTIR spectra (A) and second derivatives (B) of IAPP: 5 min after preparation (green), after 3 
days of aggregation at ambient pressure (red) and after 3 days at 3.5 kbar (blue). 
 
Figure 33 shows FTIR spectra of various IAPP samples: freshly dissolved IAPP 
and IAPP aggregated for 3 days at ambient pressure and at 3.5 kbar, respectively (all 
spectra were taken at room temperature, 25 °C). The FTIR spectrum of the freshly 
prepared IAPP sample at a concentration as high as 250 µM exhibits a IR band 
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appearing at ~1622 cm-1, likely of intermolecular parallel β-sheet structures, and a 
pronounced peak at 1673 cm-1, which is due to turns and residual trifluoracetic acid 
(TFA) in the sample. Such IR pattern is indicative of the aggregated state of IAPP 
according to the data of other amyloidogenic proteins, like insulin [Dzwolak et al., 
2004a]. 
In order to reveal the different morphological structures formed, additional AFM 
measurements were carried out for this IAPP concentration (Fig. 34). Most of the 
aggregate structures seen in the sample that was not subjected to HHP are short (< 1 µm) 
fibrils with an average of 5 - 15 nm diameters as determined from the AFM height 
profile. Such rather short fibrillar structures probably appear due to a comparably fast 
nucleation process at this high protein concentration, whereas the elongation process 
seems to be comparably slow. The pressure treated sample still contains fibrils, but also 
a significant amount of smaller oligomeric particles (of 0.5 - 1.5 nm size). 
Taking the FTIR spectroscopic and AFM results together, we may conclude that 
the sample subjected to the high pressure treatment shows less fibrillar β-sheet 
structures and a larger population of smaller amorphous aggregates with a different H-
bonding pattern. The different fibrillar and non-fibrillar amorphous/oligomeric 
morphologies found for the high pressure treated sample indicate that not all IAPP 
aggregate structures are equally sensitive to pressure, hence suggesting the existence of 
pressure resistant fibrils with densely packed cores and a population that can be 
dissociated by HHP.  
The conceptual framework for using such pressure axis experiments is as follows: 
The interior of proteins is largely composed of rather efficiently packed residues (with 
void volume on the order of 0.5 %), more likely hydrophobic than those at the surface. 
High hydrostatic pressure induces conformational fluctuations due to a decrease in the 
strength of hydrophobic interactions, finally leading to partially pressure-induced 
unfolding through transfer of water molecules into the protein interior, gradually filling 
cavities and leading to the dissociation of close hydrophobic contacts and subsequent 
swelling of the hydrophobic protein interior [Haberhold et al., 2004; Hummer et al., 
1998]. According to the literature, aggregation of the C-terminal domain of IAPP 
(amino acid sequences 20-29 and 30-37) is thought to be most likely driven by 
hydrophobic interactions. The distinctly amyloidogenic region 20-29 has been pointed  
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Panel B
 
Figure 34: AFM height images of 250 µM IAPP aggregates after 3 d without (panel A) and with pressure 
treatment at 3.5 kbar (panel B). 
 
out to be a key fibril-forming region [Ma et al., 2001]. Hence it is conceivable that the 
C-terminus of IAPP, spanning residues 20 to 37, forms a β-sheet. The secondary 
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structure predictions of human IAPP indicate that there is one potential α-helical region 
between amino acid residues 8-14, and three potential β-strand regions. A β-turn has 
been predicted at Asn31, which would result in two adjacent β-strands (32-37 and 24-
29); a third β-strand is proposed to exist in region 18-23 [Jaikaran et al., 2001]. 
According to these data, it may be concluded that IAPP has not only one but 
several amyloidogenic cores that are interacting to form an organized aggregate 
structure, and that hydrophobic interactions may drive the initial stage of the 
aggregation process. As HHP is acting to weaken or even prevent hydrophobic self-
organization, we may expect that the amyloidogenic "cores" cannot be arranged and 
packed the same way upon aggregation as they are able to do under ambient pressure 
conditions, thus leading to the formation of a more heterogeneous population of fibrils 
and smaller amorphous/oligomeric species. 
Taken all data together, a hypothetical model for IAPP fibril formation may be 
suggested: i) IAPP undergoes fast nucleation (due to several amyloidogenic "cores"), 
largely driven by hydrophobic interactions. Hence, formation and packing of fibrils is 
not perfect and mixed-registry β-sheet structures might exist, in particular at high 
protein concentrations, which can be partially dissociated by pressure leading to smaller 
aggregate structures and oligomers. HHP already as low as 3.5 kbar is sufficient to 
weaken and (at least partially) disrupt the hydrophobic cores thus leading to formation 
of a heterogeneous population of fibrillar aggregates with IR amide I' bands in the low 
wavenumber region (which is typical of a more strongly H-bonding pattern of 
intermolecular β-sheets) and a large amount of non-fibrillar smaller aggregates and 
oligomers, as detected by AFM (with IR amide I' bands in the larger wave number 
region around 1620 cm-1). ii) Our data also indicate that the early IAPP fibrils are 
sensitive to high hydrostatic pressure, similar to amorphous aggregates and inclusion 
bodies [St John et al., 1999; Foguel and Silva, 2004]. Considering the fact that high 
hydrostatic pressure is an effective means in disturbing ionic and hydrophobic 
interactions but not hydrogen bonds, we can conclude that these former two types of 
interaction are important for the stability of IAPP fibrillar aggregates, as also suggested 
in work using denaturing agents [Kayed et al., 1999]. The results may be 
physiologically relevant and may have important implications regarding the stability of 
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the IAPP fibrils against degradation, a fact that can contribute to the development of 
antagonists of the pathogenesis of type II diabetes mellitus. 
 
3.3.2. Aggregation in trifluorethanol (TFE) 
 
TFE is one of the solvents used for preparing stock solutions for IAPP studies 
[Lopes et al., 2004, 2007]. To check if a high concentration stock solution can be kept 
for longer times, 0.5% of IAPP was dissolved in trifluorethanol and incubated at room 
temperature for 7 weeks, taking FTIR spectra after 1, 7, 14 and 52 days of incubation. 
The second derivative FTIR spectra shown in figure 35 illustrate changes of secondary 
structure during incubation. 
IAPP just dissolved in TFE shows a dominant 2nd derivative peak at 1626 cm-1, 
which can be assigned to β-sheet structures and a smaller peak at 1652 cm-1, typical for 
α-helices. Minima at 1674 cm-1, observed in all spectra, are assigned to residual 
trifluoracetic acid in the sample (Fig. 35). After one day, a decrease of the β-sheet signal 
with a simultaneous increase in α-helical structures is observed. During the next 2 
weeks, α-helical structures become dominant. After 14 days, the initial β-sheet 
structures (represented by a minimum at 1626 cm-1) are completely dissociated, but a 
new type of β-strands (minima at 1630 and 1616 cm-1) starts to form. And finally after 
52 days, α-helices are completely converted into the new type of β-strands.  
Hence, during the incubation process of IAPP, two transitions have been observed: 
the first one is a non-amyloid β-sheet conversion into α-helices which is induced by 
TFE; the second one leads to aggregation of the non-native α-helices into 
amyloidogenic β-sheet structures. This suggests that α-helical structures are an on-
pathway intermediate to the amyloidogenesis of IAPP. Transient α-helical structures 
have in fact been shown to occur in some natively unstructured amyloid-forming 
proteins including IAPP [Lopes et al., 2007; Williamson and Miranker, 2007; 
Kirkitadze et al., 2001].  Hence, reported data are further indication that α-helices may 
be a rather common intermediate formed before the amyloid formation by natively 
unstructured peptides takes place [Lopes et al., 2007]. 
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Figure 35: Second derivative FTIR spectra showing changes in secondary structure of IAPP solution in 
TFE during incubation at room temperature. 
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4. Summary 
 
The number of people affected by different neurodegenerative diseases is 
considerable and increases every year. One of the characteristic hallmarks of these 
diseases is the deposition of ordered proteinacious aggregates, called amyloid. Not only 
disease-related proteins are able to form amyloid-like structures; In fact it was 
suggested that formation of amyloid fibrils can be considered a generic feature of 
polypeptide chains. Thus simple and cheaper peptides and proteins can be used as 
models for studying amyloidogenesis. Insulin and polylysine, which have been used in 
this study, are among the most common model proteins and peptides. 
A thorough study of the amyloidogenesis of insulin has been conducted. Such 
work provides a coherent and precise description of the changes of the structure of the 
protein, the partial specific volume, heat capacity, the coefficient of thermal expansion, 
as well as the adiabatic and isothermal compressibility of the protein upon partial 
unfolding, aggregation and fibril formation. Additionally, a thermodynamic study upon 
partial unfolding, aggregation and fibril formation of polylysine, and a pressure and 
TFE perturbation study of IAPP, which plays a major role in the diabetes mellitus type 
II disease, were performed. This was possible due to the application of ultrasound 
velocimetry and pressure perturbation calorimetry, complemented by differential 
scanning calorimetry, FTIR and fluorescence spectroscopy, as well as atomic force 
microscopy studies. 
The work starts with a solvational perturbation study of the insulin aggregation 
process. Three model co-solvents (ethanol, TFE and glycerol) were used for the FTIR 
study. It was shown that the presence of 20% ethanol speeds up the aggregation kinetics, 
while 20% of TFE and 20% of glycerol stabilize α-helical structures and slow down the 
aggregation process. Moreover, the secondary structures of the final aggregates, formed 
in the presence of the different co-solvents, were found to be different from those 
formed under ambient, co-solvent-free conditions. This suggests that several distinct 
amyloid states may be induced in vitro from a single protein (Fig. 36 A and B). 
Insulin amyloid fibrils can be broken into smaller pieces by using ultrasound 
treatment. Most of the broken fibrils can stick together via interactions between their 
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ends. Possibly, the termini of broken fibrils are prone to attach additional particles and 
are able to elongate effectively in such a way.  
Sonicated insulin fibrils, added to the native insulin solution at low pH, are able to 
induce the formation of amyloid (seeding-effect) under conditions, which are not 
common for nuclei formation. Moreover, two distinct insulin amyloid states, formed 
under co-solvent free conditions and in the presence of 20% ethanol, replicate their 
structure-hallmarking infrared features (Fig. 36 C and D). The cross-seeding specificity 
and the kinetic features of both amyloid types appear to mirror certain aspects of the 
prion strains phenomenon and kinetic traits observed in other amyloidosis. This 
suggests that the strain-dependent infectivity of prions is an inherent feature of protein 
amyloids and, as such, remains in accordance with the protein-only molecular basis of 
prion diseases. 
 
A 
Nucleation Elongation 
B 
Nucleation Elongation 
C 
Seeding 
D 
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Figure 36: Formation of insulin amyloid “strains” and cross-seeding. At low pH and high temperatures 
insulin forms amyloid fibrils. The fibrils exhibit different structures when formed in pure water (A) and in 
the presence of 20% ethanol (B). Short pieces of fibrils, subjected to insulin solution, are able to induce 
the formation of amyloid (seeding-effect) even at ambient temperature. The presence of seeds negates the 
environmental factor: amyloid particles, formed in the presence of 20% ethanol, are able to replicate 
when subjected to insulin solution in pure water (C), and amyloid particles formed in pure water are able 
to replicate when subjected to insulin solution in the presence of 20% ethanol (D). 
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The study of insulin aggregation under different pressures showed no major 
differences between samples aggregated under 1 and 1000 bar. The only minor 
differences were observed in the kinetics of aggregation. 
A precise and simultaneous determination of the thermodynamic variables , Cov p, 
α, βS, and βT upon unfolding and aggregation of insulin and polylysine was performed. 
It permits devising a unified thermodynamic picture of the time-dependent aggregation 
process, with highlighting the importance of volume fluctuations during unfolding and 
amyloidogenesis of the protein. The volume fluctuations appear to stem largely from 
changes in the flexibility of the protein, which is related to void volume and hydration 
changes during the various phases of the structural transformation of the protein: 
destabilization and partial unfolding of the monomer, oligomerisation, early aggregation 
and maturation of fibrils. 
A series of measurements in the absence and presence of 0.1 M NaCl revealed 
two distinctly different pathways of insulin aggregation. In the absence of screening 
ions (salt), with increasing temperature insulin starts to destabilize and unfold, and, after 
reaching a significant level of unfolding (random coil secondary structures are 
dominating), it forms compact nuclei that grow into fibrils. In the presence of 0.1 M 
NaCl, partial unfolding (the contents of disordered, random coil-like secondary 
structures is below 50%) occurs with raising temperature, forming partially unfolded 
nonfibrillar aggregates (or oligomers) around 55-60 °C. Further increase of temperature 
leads to a reorganization of the aggregate structure and formation of more compact 
nuclei which allow growth of elongated mature fibrillar species. As revealed by AFM, 
the latter process which fosters reorganization, ripening and formation of more compact 
nuclei from amorphous oligomers, leads to more crowded aggregate morphologies. 
The study of the disease-related islet amyloid polypeptide revealed its sensitivity 
to high pressure. The results may be physiologically relevant and may have important 
implications regarding the stability of the IAPP fibrils against degradation, a fact that 
can contribute to the development of antagonists of the pathogenesis of type II diabetes 
mellitus. IAPP aggregation in TFE showed a novel β-to-α-to-β secondary structural 
transition. The data indicate that formation of α-helices may be a rather common event 
preceeding amyloid formation from natively-unstructured peptides. 
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5. Zusammenfassung 
 
Die Anzahl der Personen, die an unterschiedlichen neurodegenerativen 
Erkrankungen leiden, ist erheblich und steigt jedes Jahr weiter an. Eines der 
charakteristischen Merkmale solcher Krankheiten ist das Vorkommen von geordneten 
Protein-Aggregaten, so genannten Amyloiden. Aber nicht nur mit Krankheiten 
assoziierte Proteine sind in der Lage, Amyloid-Strukturen auszubilden. Es wurde 
vermutet, dass Polypeptidketten generell Amyloid-Fibrillen bilden können. Daher 
werden einfache und kostengünstige Peptide und Proteine als Modellsubstanzen dazu 
genutzt, die Amyloidogenese zu studieren. Insulin und Polylysin, die in dieser Studie 
verwendet wurden, gehören zu den gebräuchlichsten Modellproteinen und – peptiden. 
In dieser Arbeit wurde eine umfassende Untersuchung der Amyloidogenese des 
Insulins  durchgeführt, die eine schlüssige und präzise Beschreibung der Veränderungen 
der Proteinstruktur, des spezifischen partiellen Volumens, der Wärmekapazität, des 
thermischen Ausdehnungskoeffizienten so wie der adiabatischen und isotermen 
Kompressibilität des Proteins bei seiner partiellen Entfaltung, Aggregation und 
Fibrillbildung  liefert. 
Zusätzlich wurde eine thermodynamische Untersuchung der partiellen Entfaltung, 
Aggregation und Fibrillbildung von Polylysin durchgeführt und der Einfluss von 
Druckänderungen und TFE auf die Aggregation von IAPP studiert. Dies war durch den 
Einsatz von Ultraschallgeschwindigkeitsmessungen und der Druckperturbations-
kalorimetrie, ergänzt durch DSC, FTIR- und Fluoreszenz-Spektroskopie sowie 
Rasterkraftmikroskopie möglich.  
Zunächst wurde der Einfluss verschiedener Co-Lösungsmittel auf die 
Insulinaggregation untersucht. Drei Modell-Cosolventien wurden für die FTIR-
Untersuchungen benutzt: Ethanol, TFE und Gylcerol. Es konnte gezeigt werden, dass 
die Anwesenheit von 20% Ethanol die Aggregations-Kinetik beschleunigt, während 
20% TFE und besonders 20% Glycerol α-helikale Strukturen stabilisieren und somit die 
Aggregationsrate herabsetzen. Des Weiteren ist die Sekundärstruktur, die in 
Anwesenheit von Cosolventien ausgebildet wird, unterschiedlich von der ohne diesen 
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Substanzen gebildeten Struktur. Dies lässt darauf schließen, dass es in vitro mehrere 
verschiedene Amyloid-Zustände für ein einzelnes Protein gibt (Abb. 36 A und B). 
Insulinfibrillen können mittels Ultraschallbehandlung in kleinere Stücke 
gebrochen werden. Die meisten gebrochenen Fibrillen können an ihren Enden 
zusammenhängen. Möglicherweise besitzen die Enden der gebrochenen Fibrillen eine 
erhöhte Affinität für die Anlagerung weiterer Partikel und sind so in der Lage, sich 
effizient zu verlängern. 
 
A 
Keimbildung Verlängerung 
B 
Keimbildung Verlängerung 
C 
Impfung 
D 
Impfung 
 
Abbildung 36: Bildung von Inulin-Amyloid-„Strängen” und „cross-seeding“. Bei niedrigem pH und 
hoher Temperatur bilden sich Insulinfibrillen. Die Form von in reinem Wasser (A) und in Anwesenheit 
von 20% Ethanol (B) gebildeten Fibrillen ist unterschiedlich. Kurze Stücke von Fibrillen, induziert in 
eine Insulinlösung, können selbst bei Raumtemperatur die Bildung von Amyloid induzieren. Der Effekt 
von solchen Kristallisationskeimen ist erheblich stärker als Faktoren der Umgebung: Amyloidpartikel, die 
in einer Lösung mit 20% Ethanol gebildet wurden, können sich, in eine Insulinlösung in reinem Wasser 
gegeben, vervielfältigen (C) und Amyloidpartikel, die in reinem Wasser entstanden, wachsen, ihre 
Struktur beibehaltend, weiter in einer Insulinlösung, die 20% Ethanol enthält (D). 
 
Zu einer nativen Insulinlösung mit geringem pH-Wert hinzugefügte 
ultraschallbehandelte Insulinfibrillen induzieren strukturgleiche Amyloide selbst unter 
Lösungsmittel-Bedingungen, die für die Ausbildung von Fibrillkeimen ungünstig sind. 
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Darüber hinaus bleiben die strukturkennzeichnenden Infraroteingenschaften dieser 
beiden Amyloidzustände auch in der jeweils anderen Lösung erhalten (Abb. 36 C und 
D).  Diese „cross-seeding“-Spezifität und die kinetischen Eigenschaften dieser beiden 
Amyloidtypen scheinen das bereits bekannte „Prion-Strain-Phänomen“ und die 
kinetischen Charakteristika widerzuspiegeln, die bereits bei anderen amyloidbildenden 
Proteinen gefunden wurden. Daraus lässt sich schließen, dass es sich bei dem 
strangabhängigen Wachstum von Prionen um eine inhärente Eigenschaft von 
Proteinamyloiden handelt. 
Die Untersuchung von Insulin bei unterschiedlichen Drücken zeigte keine 
wesentlichen Unterschiede der Aggregation bei 1 bar und 1000 bar. Einzig ein geringer 
Unterschied in der Kinetik der Aggregation konnte beobachtet werden. 
Die thermodynamischen Größen , Cov p, α, βS, und βT bei der Entfaltung und 
Aggregation des Insulins und des Polylysins wurden gemessen. Daraus konnte ein 
einheitliches Bild der zeitabhängigen Aggregation entwickelt werden, das die 
Wichtigkeit von Volumenfluktuationen während des Enfaltungsprozesses und der 
Amyloidogenese der Proteine hervorhebt. Diese Fluktuationen scheinen hauptsächlich 
durch Änderungen der Flexibilität des Proteins, die eng mit dem Leervolumen und 
Hydratationsänderungen während der zahlreichen Phasen der Strukturänderung 
(Destabilisierung und partielle Entfaltung des Monomers, Oligomerisierung, erste 
Aggregation und Wachstum der Fibrillen) verbunden sind, hervorgerufen zu werden. 
Schließlich zeigten sich in einer Reihe von Messungen ohne und mit 0,1 M NaCl 
zwei völlig verschiedene Wege der Aggregation von Insulin. In Abwesenheit 
ladungsabschirmender Ionen (Salz) wird das Insulin mit steigender Temperatur 
destabilisiert und entfaltet. Wenn ein gewisses Maß an Entfaltung erreicht ist (wenn die 
ungeordneten Bereiche dominieren), bildet das Insulin kompakte Keime, die dann zu 
Fibrillen anwachsen. In Anwesenheit von 0,1 M NaCl kommt es mit steigender 
Temperatur zu einer partiellen Entfaltung (der „random-coil“-Anteil liegt unter 50%) 
und zur Bildung von partiell entfalteten nicht-fibrillaren Aggregaten (oder Oligomeren) 
bei etwa 55-60 °C. Eine weitere Erhöhung der Temperatur führt zu einer Reorganisation 
der Aggregatstruktur und der Bildung kompakterer Keime, die ein Wachstum längerer 
Fibrillen erlauben. Die AFM-Messungen zeigen, dass der letzte Prozess, die 
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Reorganisation, Reifung und Bildung kompakterer Keime aus amorphen Oligomeren zu 
einer dichteren Aggregatmorphologie führt. 
In der Untersuchung an IAPP trat eine besondere Sensitivität des Proteins für 
hohen Druck zum Vorschein. Die gewonnen Ergebnisse sind möglicherweise 
physiologisch relevant und wichtig für das Verständnis der Stabilität von IAPP-Fibrillen. 
Die daraus gewonnenen Kenntnisse lassen sich möglicherweise für die Entwicklung 
von Antagonisten der Krankheit Diabetes Mellitus Typ II nutzen. Die Aggregation von 
IAPP in TFE zeigte einen interessanten β-zu-α-zu-β Sekundärstrukturübergang. Dies ist 
ein Hinweis darauf, dass die transiente Ausbildung von α-Helices wahrscheinlich ein 
allgemeines Phänomen bei der Amyloidbildung nativ-unstrukturierter Peptide ist. 
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6. Appendix 
 
6.1. The shape of amyloid fibrils 
 
Several years ago, the existence of circular-shaped amyloid, promoted by high 
pressure was shown [Jansen et al., 2004]. But can such a shape be observed only after 
high pressure treatment? And will the same conditions always promote the same shape 
of fibrils? 
 
 
Figure 36: Insulin amyloid fibrils, formed in pH 2, at 60 °C. Straight fibrils, some circles and even some 
kind of network tructure can be formed under similar conditions. 
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Figures 36 and 37 show different shapes of insulin amyloid fibrils, grown in water 
(pH 2) or in presence of 20% TFE. The diversity of shapes of fibrils, formed under the 
same experimental conditions reflects the stochastic nature of the process and the high 
degree of polymorphism present in this ???. 
 
 
Figure 37: Insulin amyloid fibrils, formed at pH 2, in the presence of 20% TFE at 60 °C. Most of the 
samples show straight unbranched fibrils, but samples with circular fibrils were also observed. 
 
6.2. Handedness of insulin amyloid 
 
Studies of the insulin fibril structure suggest that insulin is able to form left-
handed fibrils [Jimenez et al., 2002]. Most of the microscopy studies are able to confirm 
it. But there are several articles, showing a model (Fig. 2) [Kurnana et al., 2003] or even 
AFM images [Jansen et al., 2005] of right-handed insulin amyloid fibrils. Do right-
handed insulin fibrils exist, and are there any special conditions to form such fibrils? 
Figures 38 and 39 exhibit many of left-handed fibrils and the only right-handed 
one that I was able to find during 3 years. The inability to find more right-handed fibrils 
in the same sample and in other samples, prepared the same way, suggests that 
formation of right-handed fibrils may not depend on environmental conditions, but may 
be formed at any conditions, with a much lower probability than left handed ones, 
however. Moreover, it was recently reported that insulin possesses the ability to form 
aggregates with uniformly biased chiral moieties, which bind and twist likewise an 
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achiral dye [Dzwolak et al., 2007]. Perhaps these findings can lead to the discovery of 
the special conditions needed to form different handedness of fibrils. 
 
 
Figure 38: Fibrils, formed by insulin are left-handed… 
 
 
100 nm 
Figure 39: …but occasionally  right-handed fibril can be formed s well.  
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6.3. Layers of IAPP fibrils 
 
While carrying one AFM measurement on IAPP amyloid fibrils I have observed 
that amyloid fibrils are able to form densely packed monolayers (Figs. 40-41). 5µM 
IAPP was kept under 3000 bar pressure at 37°C for 3 days, diluted 5 times, put on the 
mica and left to dry. Upon drying the pressure-treated protein started aggregation 
directly on the mica, leading to layers of fibrils (Fig. 40). Such behavior of IAPP after 
pressure treatment was spotted only once, subsequent samples subjected to the same 
treatment did not show any similar behavior. 
 
 
Figure 40: Layers of IAPP fibrils, formed on the mica after pressure treatment. 
 
Additionally, similar layers of fibrils were observed in samples of IAPP, subjected 
to sonication before applying to mica and leaving to dry (Fig. 42). These findings 
suggest that IAPP subjected to critical conditions (e.g. high pressure or ultrasonic 
waves), which lead to the partial break-up into smaller, highly reactive species, has the 
tendency of fast elongation and the ability to form layer-like structures, when drying at 
planar solid supports. 
In both cases, layers are formed from highly uniform, ~4 nm diameter fibrils. A 
deeper look into the images reveals that the fibrils tend to grow in a tree-like manner, 
with dividing into branches during the growth process. Such branching mechanism of 
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growth was proposed for fibrils of the prion protein [Baskakov 2007] and is typical for 
diffusion-limited aggregation reactions. 
 
 
Figure 41: The art of amyloid fibrils. Fibrils of IAPP, grown on mica after sonication.  
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